Inhibition	O
of	O
alpha	B-protein
interferon	I-protein
but	O
not	O
gamma	B-protein
interferon	I-protein
signal	O
transduction	O
by	O
phorbol	O
esters	O
is	O
mediated	O
by	O
a	O
tyrosine	B-protein
phosphatase	I-protein
.	O

Previous	O
studies	O
have	O
indicated	O
that	O
the	O
expression	O
of	O
viral	O
oncoproteins	O
,	O
cell	O
transformation	O
,	O
or	O
phorbol	O
ester	O
treatment	O
of	O
cells	O
can	O
inhibit	O
alpha/beta	O
interferon	O
(	O
IFN-alpha/beta	O
)	O
-induced	O
gene	O
expression	O
.	O

The	O
mechanisms	O
by	O
which	O
these	O
promoters	O
of	O
cell	O
growth	O
exert	O
their	O
inhibitory	O
effects	O
vary	O
,	O
but	O
in	O
most	O
instances	O
they	O
involve	O
a	O
disruption	O
of	O
the	O
IFN-alpha/beta-induced	O
transcription	O
complex	O
ISGF3	O
such	O
that	O
the	O
DNA-binding	O
component	O
of	O
this	O
complex	O
(	O
the	O
48-kDa	O
ISGF3gamma	O
protein	O
)	O
does	O
not	O
bind	O
to	O
the	O
interferon-stimulated	O
response	O
element	O
(	O
ISRE	O
)	O
.	O

In	O
this	O
report	O
,	O
we	O
demonstrated	O
that	O
phorbol	O
ester	O
treatment	O
of	O
human	O
peripheral	O
blood	O
monocytes	O
dramatically	O
inhibits	O
activation	O
of	O
IFN-alpha/B-stimulated	O
early	O
response	O
genes	O
but	O
by	O
a	O
mechanism	O
which	O
does	O
not	O
involve	O
abrogation	O
of	O
the	O
ISRE	O
binding	O
of	O
ISGF3gamma	O
.	O

Phorbol	O
ester	O
treatment	O
of	O
monocytes	O
inhibited	O
IFN	O
alpha-stimulated	O
tyrosine	O
phosphorylation	O
of	O
the	O
transcription	B-protein
factors	I-protein
Stat1alpha	B-protein
,	O
Stat2	B-protein
,	O
and	O
Stat3	B-protein
and	O
of	O
the	O
tyrosine	B-protein
kinase	I-protein
Tyk2	B-protein
but	O
had	O
no	O
effect	O
on	O
IFN-gamma	B-protein
activation	O
of	O
Stat1alpha	B-protein
.	O

IFNalpha-stimulated	O
tyrosine	O
phosphorylation	O
of	O
Jak1	B-protein
and	O
the	O
alpha	B-protein
subunit	I-protein
of	O
the	O
IFN-alpha	B-protein
receptor	I-protein
were	O
unaffected	O
by	O
phorbol	O
12-myristate	O
13-acetate	O
(	O
PMA	O
)	O
.	O

Moreover	O
,	O
PMA	O
caused	O
the	O
dephosphorylation	O
of	O
Tyk2	B-protein
but	O
not	O
of	O
Jak1	B-protein
,	O
which	O
was	O
activated	O
by	O
IFN	B-protein
.	O

Pretreatment	O
of	O
cells	O
with	O
vanadate	O
prevented	O
the	O
effects	O
of	O
PMA	O
with	O
regard	O
to	O
PMA-induced	O
Tyk2	B-protein
dephosphorylation	O
.	O

These	O
observations	O
suggest	O
that	O
PMA	O
exerts	O
its	O
inhibitory	O
effects	O
by	O
activation	O
of	O
a	O
tyrosine	B-protein
phosphatase	I-protein
which	O
selectively	O
regulates	O
Tyk2	B-protein
but	O
not	O
Jak1	B-protein
activity	O
.	O

MoLECULAR	NULL
AND	NULL
CELLULAR	NULL
BroLoGYy	NULL
,	NULL
Apr	NULL
.	NULL

1996	NULL
,	NULL
p.	NULL
1419-1424	NULL
0270-7306/96/	NULL
$	NULL
04.00+0	NULL
Copyright	NULL
©	NULL
1996	NULL
,	NULL
American	NULL
Society	NULL
for	NULL
Microbiology	NULL
Vol	NULL
.	NULL

16	NULL
,	NULL
No	NULL
.	NULL

4	NULL
Inhibition	NULL
of	NULL
Alpha	NULL
Interferon	NULL
but	NULL
Not	NULL
Gamma	NULL
Interferon	NULL
Signal	NULL
Transduction	NULL
by	NULL
Phorbol	NULL
Esters	NULL
Is	NULL
Mediated	NULL
by	NULL
a	NULL
Tyrosine	NULL
Phosphatase	NULL
EMANUEL	NULL
PETRICOIN	NULL
III	NULL
,	NULL
MICHAEL	NULL
DAVID	NULL
,	NULL
KENICHI	NULL
IGARASHI	NULL
,	NULL
'	NULL
CHRISTOPHER	NULL
BENJAMIN	NULL
,	NULL
*	NULL
LEONA	NULL
LING	NULL
,	NULL
``	NULL
SUSAN	NULL
GOELZ	NULL
,	NULL
*	NULL
DAVID	NULL
S.	NULL
FINBLOOM	NULL
,	NULL
*	NULL
anp	NULL
ANDREW	NULL
C	NULL
.	NULL

LARNER	NULL
!	NULL

*	NULL
Division	NULL
of	NULL
Cytokine	NULL
Biology	NULL
,	NULL
Center	NULL
for	NULL
Biologics	NULL
Evaluation	NULL
and	NULL
Research	NULL
,	NULL
Bethesda	NULL
,	NULL
Maryland	NULL
20892	NULL
,	NULL
``	NULL
and	NULL
Biogen	NULL
Inc.	NULL
,	NULL
Cambridge	NULL
,	NULL
Massachusetts	NULL
02142	NULL
``	NULL
Received	NULL
27	NULL
September	NULL
1995/Returned	NULL
for	NULL
modification	NULL
15	NULL
November	NULL
1995/Accepted	NULL
8	NULL
January	NULL
1996	NULL
Previous	NULL
studies	NULL
have	NULL
indicated	NULL
that	NULL
the	NULL
expression	NULL
of	NULL
viral	NULL
oncoproteins	NULL
,	NULL
cell	NULL
transformation	NULL
,	NULL
or	NULL
phorbol	NULL
ester	NULL
treatment	NULL
of	NULL
cells	NULL
can	NULL
inhibit	NULL
alpha/beta	NULL
interferon	NULL
(	NULL
IFN-	NULL
«	NULL
@	NULL
/f§	NULL
)	NULL
-induced	NULL
gene	NULL
expression	NULL
.	NULL

The	NULL
mechanisms	NULL
by	NULL
which	NULL
these	NULL
promoters	NULL
of	NULL
cell	NULL
growth	NULL
exert	NULL
their	NULL
inhibitory	NULL
effects	NULL
vary	NULL
,	NULL
but	NULL
in	NULL
most	NULL
instances	NULL
they	NULL
involve	NULL
a	NULL
disruption	NULL
of	NULL
the	NULL
IFN-	NULL
«	NULL
@	NULL
/f-induced	NULL
transcription	NULL
complex	NULL
ISGF3	NULL
such	NULL
that	NULL
the	NULL
DNA-binding	NULL
component	NULL
of	NULL
this	NULL
complex	NULL
(	NULL
the	NULL
48-kDa	NULL
ISGF3y	NULL
protein	NULL
)	NULL
does	NULL
not	NULL
bind	NULL
to	NULL
the	NULL
interferon-stimulated	NULL
response	NULL
element	NULL
(	NULL
ISRE	NULL
)	NULL
.	NULL

In	NULL
this	NULL
report	NULL
,	NULL
we	NULL
demonstrate	NULL
that	NULL
phorbol	NULL
ester	NULL
treatment	NULL
of	NULL
human	NULL
peripheral	NULL
blood	NULL
monocytes	NULL
dramatically	NULL
inhibits	NULL
activation	NULL
of	NULL
IFN-o/f-stimulated	NULL
early	NULL
response	NULL
genes	NULL
but	NULL
by	NULL
a	NULL
mechanism	NULL
which	NULL
does	NULL
not	NULL
involve	NULL
abrogation	NULL
of	NULL
the	NULL
ISRE	NULL
binding	NULL
of	NULL
ISGF3y	NULL
.	NULL

Phorbol	NULL
ester	NULL
treatment	NULL
of	NULL
monocytes	NULL
inhibited	NULL
IFNa-stimulated	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
the	NULL
transcription	NULL
factors	NULL
Statla	NULL
,	NULL
Stat2	NULL
,	NULL
and	NULL
Stat3	NULL
and	NULL
of	NULL
the	NULL
tyrosine	NULL
kinase	NULL
Tyk2	NULL
but	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
IFN-y	NULL
activation	NULL
of	NULL
Statl	NULL
«	NULL
.	NULL

IFNa-stimulated	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
Jak1	NULL
and	NULL
the	NULL
«	NULL
subunit	NULL
of	NULL
the	NULL
IFN-a	NULL
«	NULL
receptor	NULL
were	NULL
unaffected	NULL
by	NULL
phorbol	NULL
12-myristate	NULL
13-acetate	NULL
(	NULL
PMA	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
PMA	NULL
caused	NULL
the	NULL
dephosphorylation	NULL
of	NULL
Tyk2	NULL
but	NULL
not	NULL
of	NULL
Jak1	NULL
,	NULL
which	NULL
was	NULL
activated	NULL
by	NULL
IFN	NULL
.	NULL

Pretreatment	NULL
of	NULL
cells	NULL
with	NULL
vanadate	NULL
prevented	NULL
the	NULL
effects	NULL
of	NULL
PMA	NULL
with	NULL
regard	NULL
to	NULL
PMA-induced	NULL
Tyk2	NULL
dephosphorylation	NULL
.	NULL

These	NULL
observations	NULL
suggest	NULL
that	NULL
PMA	NULL
exerts	NULL
its	NULL
inhibitory	NULL
effects	NULL
by	NULL
activation	NULL
of	NULL
a	NULL
tyrosine	NULL
phosphatase	NULL
which	NULL
selectively	NULL
regulates	NULL
Tyk2	NULL
but	NULL
not	NULL
Jakl	NULL
activity	NULL
.	NULL

Rapid	NULL
activation	NULL
of	NULL
cellular	NULL
genes	NULL
by	NULL
exposure	NULL
of	NULL
cells	NULL
to	NULL
interferons	NULL
utilizes	NULL
a	NULL
signaling	NULL
pathway	NULL
which	NULL
requires	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
a	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
termed	NULL
signal	NULL
transducers	NULL
and	NULL
activators	NULL
of	NULL
transcription	NULL
(	NULL
Stat	NULL
pro-teins	NULL
)	NULL
(	NULL
15	NULL
,	NULL
20	NULL
)	NULL
.	NULL

The	NULL
Janus	NULL
family	NULL
of	NULL
tyrosine	NULL
kinases	NULL
are	NULL
also	NULL
integral	NULL
components	NULL
of	NULL
this	NULL
signaling	NULL
cascade	NULL
(	NULL
15	NULL
)	NULL
.	NULL

Tyrosine	NULL
phosphorylation	NULL
of	NULL
Stat	NULL
proteins	NULL
enables	NULL
them	NULL
to	NULL
translocate	NULL
to	NULL
the	NULL
nucleus	NULL
and	NULL
bind	NULL
to	NULL
enhancers	NULL
with	NULL
conserved	NULL
sequences	NULL
located	NULL
within	NULL
the	NULL
promoters	NULL
of	NULL
responsive	NULL
genes	NULL
.	NULL

Two	NULL
classes	NULL
of	NULL
enhancers	NULL
which	NULL
are	NULL
necessary	NULL
and	NULL
sufficient	NULL
for	NULL
activation	NULL
of	NULL
genes	NULL
by	NULL
alpha/beta	NULL
or	NULL
gamma	NULL
interferon	NULL
(	NULL
IFN-	NULL
«	NULL
/B	NULL
and	NULL
IFN-y	NULL
)	NULL
have	NULL
been	NULL
characterized	NULL
.	NULL

One	NULL
is	NULL
termed	NULL
the	NULL
interferon-stimulated	NULL
response	NULL
element	NULL
(	NULL
ISRE	NULL
)	NULL
,	NULL
and	NULL
the	NULL
other	NULL
is	NULL
the	NULL
gamma	NULL
interferon	NULL
activation	NULL
sequence	NULL
(	NULL
GAS	NULL
)	NULL
.	NULL

Either	NULL
enhancer	NULL
can	NULL
be	NULL
activated	NULL
by	NULL
while	NULL
IFN-y-stimulated	NULL
genes	NULL
utilize	NULL
primarily	NULL
the	NULL
GAS	NULL
element	NULL
(	NULL
20	NULL
)	NULL
.	NULL

Tyrosine-phosphorylated	NULL
Statl	NULL
and	NULL
Stat2	NULL
interact	NULL
with	NULL
the	NULL
ISRE	NULL
primarily	NULL
through	NULL
their	NULL
association	NULL
with	NULL
ISGF3qy	NULL
,	NULL
a	NULL
48-kDa	NULL
DNA-binding	NULL
protein	NULL
which	NULL
is	NULL
a	NULL
member	NULL
of	NULL
the	NULL
IFN	NULL
regulatory	NULL
factor	NULL
family	NULL
of	NULL
DNA-binding	NULL
proteins	NULL
(	NULL
32	NULL
)	NULL
.	NULL

The	NULL
complex	NULL
which	NULL
contains	NULL
these	NULL
three	NULL
components	NULL
has	NULL
been	NULL
termed	NULL
ISGF3	NULL
(	NULL
21	NULL
)	NULL
.	NULL

Statl	NULL
and	NULL
other	NULL
members	NULL
of	NULL
this	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
(	NULL
ex-cluding	NULL
Stat	NULL
?	NULL
)	NULL

interact	NULL
with	NULL
GAS-like	NULL
sequences	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
ISGF3y	NULL
(	NULL
13	NULL
,	NULL
35	NULL
)	NULL
.	NULL

Inhibition	NULL
of	NULL
IFN-stimulated	NULL
gene	NULL
expression	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
occur	NULL
under	NULL
a	NULL
variety	NULL
of	NULL
circumstances	NULL
related	NULL
to	NULL
enhanced	NULL
cellular	NULL
growth	NULL
and	NULL
viral	NULL
infection	NULL
.	NULL

The	NULL
expression	NULL
of	NULL
several	NULL
viral	NULL
oncoproteins	NULL
,	NULL
including	NULL
adenovirus	NULL
E1A	NULL
,	NULL
human	NULL
papillomavirus	NULL
E6/E7	NULL
,	NULL
and	NULL
the	NULL
Epstein-Barr	NULL
virus	NULL
nuclear	NULL
an	NULL
*	NULL
Corresponding	NULL
author	NULL
.	NULL

Mailing	NULL
address	NULL
:	NULL
Division	NULL
of	NULL
Cytokine	NULL
Biology	NULL
,	NULL
Center	NULL
for	NULL
Biologics	NULL
Evaluation	NULL
and	NULL
Research	NULL
,	NULL
8800	NULL
Rockville	NULL
Pike	NULL
,	NULL
Bethesda	NULL
,	NULL
MD	NULL
20892	NULL
.	NULL

1419	NULL
tigen	NULL
2	NULL
inhibits	NULL
the	NULL
activation	NULL
of	NULL
IFN-	NULL
«	NULL
/B-stimulated	NULL
genes	NULL
(	NULL
1	NULL
,	NULL
11	NULL
,	NULL
16	NULL
,	NULL
17	NULL
)	NULL
.	NULL

Many	NULL
transformed	NULL
cell	NULL
lines	NULL
also	NULL
display	NULL
severely	NULL
diminished	NULL
IFN-	NULL
«	NULL
/B-stimulated	NULL
formation	NULL
of	NULL
ISGF3	NULL
and	NULL
expression	NULL
of	NULL
ISGF3-regulated	NULL
genes	NULL
(	NULL
25	NULL
)	NULL
.	NULL

Several	NULL
viruses	NULL
that	NULL
mediate	NULL
inhibition	NULL
of	NULL
IFN	NULL
activation	NULL
of	NULL
cellular	NULL
genes	NULL
have	NULL
been	NULL
described	NULL
(	NULL
1	NULL
,	NULL
3	NULL
,	NULL
11	NULL
,	NULL
16	NULL
,	NULL
17	NULL
,	NULL
29	NULL
)	NULL
.	NULL

In	NULL
the	NULL
case	NULL
of	NULL
infection	NULL
with	NULL
vaccinia	NULL
virus	NULL
,	NULL
a	NULL
soluble	NULL
IFN	NULL
receptor	NULL
which	NULL
interferes	NULL
with	NULL
the	NULL
actions	NULL
of	NULL
IFN	NULL
is	NULL
expressed	NULL
(	NULL
3	NULL
,	NULL
29	NULL
)	NULL
.	NULL

Expression	NULL
of	NULL
the	NULL
Epstein-Barr	NULL
virus	NULL
nuclear	NULL
antigen	NULL
2	NULL
gene	NULL
inhibits	NULL
IFN-	NULL
«	NULL
-induced	NULL
expression	NULL
of	NULL
ISRE-dependent	NULL
genes	NULL
but	NULL
has	NULL
no	NULL
effect	NULL
on	NULL
IFN-	NULL
«	NULL
-induced	NULL
ISGF3	NULL
formation	NULL
(	NULL
17	NULL
)	NULL
.	NULL

In	NULL
several	NULL
other	NULL
cases	NULL
thus	NULL
far	NULL
examined	NULL
,	NULL
inhibition	NULL
of	NULL
IFN-	NULL
«	NULL
/B-stimulated	NULL
genes	NULL
involves	NULL
the	NULL
expression	NULL
of	NULL
a	NULL
cellular	NULL
compet-itor	NULL
(	NULL
s	NULL
)	NULL
which	NULL
interacts	NULL
with	NULL
ISGF3qy	NULL
such	NULL
that	NULL
it	NULL
can	NULL
not	NULL
form	NULL
a	NULL
stable	NULL
complex	NULL
with	NULL
Statl	NULL
and	NULL
Stat2	NULL
(	NULL
1	NULL
,	NULL
11	NULL
,	NULL
16	NULL
,	NULL
17	NULL
,	NULL
24	NULL
,	NULL
25	NULL
)	NULL
.	NULL

In	NULL
fact	NULL
,	NULL
in	NULL
several	NULL
cervical	NULL
cancer	NULL
cell	NULL
lines	NULL
,	NULL
the	NULL
activity	NULL
of	NULL
this	NULL
competitor	NULL
,	NULL
termed	NULL
TKO	NULL
,	NULL
can	NULL
be	NULL
assayed	NULL
in	NULL
vitro	NULL
by	NULL
its	NULL
ability	NULL
to	NULL
disrupt	NULL
preformed	NULL
ISGF3	NULL
and	NULL
to	NULL
bind	NULL
ISGF3y	NULL
directly	NULL
(	NULL
25	NULL
)	NULL
.	NULL

Phorbol	NULL
ester	NULL
treatment	NULL
of	NULL
primary	NULL
human	NULL
fibroblasts	NULL
results	NULL
in	NULL
inhibition	NULL
of	NULL
IFN-	NULL
«	NULL
-induced	NULL
gene	NULL
expression	NULL
by	NULL
disrupting	NULL
the	NULL
ISGF3y-Stat	NULL
protein	NULL
interactions	NULL
(	NULL
24	NULL
)	NULL
.	NULL

Because	NULL
the	NULL
inhibitory	NULL
effects	NULL
of	NULL
phorbol	NULL
12-myristate	NULL
13-acetate	NULL
(	NULL
PMA	NULL
)	NULL
with	NULL
regard	NULL
to	NULL
IFN-stimulated	NULL
gene	NULL
expression	NULL
were	NULL
cell	NULL
specific	NULL
and	NULL
were	NULL
most	NULL
pronounced	NULL
in	NULL
primary	NULL
cells	NULL
(	NULL
2	NULL
)	NULL
,	NULL
we	NULL
decided	NULL
to	NULL
examine	NULL
the	NULL
actions	NULL
of	NULL
this	NULL
growth	NULL
promoter	NULL
in	NULL
primary	NULL
peripheral	NULL
blood	NULL
monocytes	NULL
.	NULL

In	NULL
these	NULL
cells	NULL
,	NULL
PMA	NULL
caused	NULL
dramatic	NULL
inhibition	NULL
of	NULL
IFN-	NULL
«	NULL
/B-induced	NULL
gene	NULL
expression	NULL
by	NULL
selectively	NULL
enhance-ing	NULL
the	NULL
dephosphorylation	NULL
of	NULL
the	NULL
Tyk2	NULL
kinase	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Cells	NULL
and	NULL
reagents	NULL
.	NULL

Human	NULL
monocytes	NULL
were	NULL
purified	NULL
(	NULL
>	NULL
95	NULL
%	NULL
)	NULL
by	NULL
leukapheresis	NULL
of	NULL
normal	NULL
volunteers	NULL
followed	NULL
by	NULL
Ficoll-Hypaque	NULL
sedimentation	NULL
and	NULL
counter	NULL
1420	NULL
PETRICOIN	NULL
ET	NULL
AL	NULL
.	NULL

A	NULL
___ISG15	NULL
__	NULL
___	NULL
1	NULL
$	NULL
G	NULL
@	NULL
54	NULL
__	NULL
U	NULL
<	NULL
5	NULL
as	NULL
U	NULL
<	NULL
3	NULL
{	NULL
<	NULL
3	NULL
2	NULL
sz	NULL
2	NULL
sz	NULL
5	NULL
2	NULL
&	NULL
2	NULL
&	NULL
5	NULL
E2	NULL
&	NULL
&	NULL
-	NULL
%	NULL
GAPDH	NULL
GAPDH	NULL
IFN-2	NULL
9-27	NULL
a	NULL
<	NULL
5	NULL
<	NULL
3	NULL
U	NULL
<	NULL
3	NULL
£53	NULL
2	NULL
Sz	NULL
2	NULL
Sz	NULL
5	NULL
&	NULL
&	NULL
ZE	NULL
5	NULL
£	NULL
£	NULL
26	NULL
%	NULL
(	NULL
an	NULL
GAPDH	NULL
GAPDH	NULL
GAPDH	NULL
<	NULL
e	NULL
am	NULL
<	NULL
e	NULL
)	NULL
Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

CTL	NULL
PMA	NULL
©	NULL
-	NULL
&	NULL
©	NULL
IFNa	NULL
:	NULL
PMA/IENG	NULL
:	NULL
¢	NULL
#	NULL
a	NULL
a	NULL
1SG54	NULL
actin	NULL
IFN-2	NULL
GAPDH	NULL
9-27	NULL
|	NULL
ISG15	NULL
pGEM	NULL
FIG	NULL
.	NULL

1	NULL
.	NULL

Phorbol	NULL
ester	NULL
treatment	NULL
of	NULL
monocytes	NULL
inhibits	NULL
IFN-	NULL
«	NULL
-	NULL
but	NULL
not	NULL
IFN-y-stimulated	NULL
gene	NULL
expression	NULL
.	NULL

Primary	NULL
peripheral	NULL
blood	NULL
monocytes	NULL
were	NULL
isolated	NULL
from	NULL
normal	NULL
volunteers	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
35	NULL
)	NULL
and	NULL
incubated	NULL
with	NULL
10~®	NULL
M	NULL
PMA	NULL
for	NULL
1	NULL
h	NULL
at	NULL
37°C	NULL
,	NULL
at	NULL
which	NULL
time	NULL
either	NULL
IFN-	NULL
«	NULL
(	NULL
10°	NULL
U/ml	NULL
!	NULL
)	NULL

or	NULL
IFN-y	NULL
(	NULL
10	NULL
ng/ml	NULL
)	NULL
was	NULL
added	NULL
to	NULL
some	NULL
of	NULL
the	NULL
samples	NULL
for	NULL
an	NULL
additional	NULL
1	NULL
h.	NULL
(	NULL
A	NULL
)	NULL
Total	NULL
cellular	NULL
RNA	NULL
was	NULL
isolated	NULL
and	NULL
hybridized	NULL
with	NULL
antisense	NULL
riboprobes	NULL
corresponding	NULL
to	NULL
several	NULL
known	NULL
IFN-	NULL
«	NULL
-induced	NULL
genes	NULL
including	NULL
ISG15	NULL
(	NULL
27	NULL
)	NULL
,	NULL
ISG54	NULL
(	NULL
2	NULL
)	NULL
,	NULL
IFN-2	NULL
(	NULL
2	NULL
)	NULL
,	NULL
and	NULL
9-27	NULL
(	NULL
28	NULL
)	NULL
.	NULL

CTL	NULL
,	NULL
control	NULL
.	NULL

(	NULL
B	NULL
)	NULL
The	NULL
IFN-y	NULL
induced	NULL
RNA	NULL
for	NULL
the	NULL
high-affinity	NULL
receptor	NULL
for	NULL
Fey	NULL
.	NULL

A	NULL
riboprobe	NULL
corresponding	NULL
to	NULL
glyceraldehyde	NULL
phosphate-3-dehydrogenase	NULL
was	NULL
included	NULL
in	NULL
each	NULL
hybridization	NULL
(	NULL
in	NULL
panels	NULL
A	NULL
and	NULL
B	NULL
)	NULL
to	NULL
ensure	NULL
that	NULL
equal	NULL
amounts	NULL
of	NULL
RNA	NULL
were	NULL
analyzed	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Nuclear	NULL
run-on	NULL
assays	NULL
were	NULL
performed	NULL
on	NULL
monocytes	NULL
incubated	NULL
with	NULL
either	NULL
PMA	NULL
or	NULL
IFN-	NULL
«	NULL
plus	NULL
PMA	NULL
as	NULL
in	NULL
panel	NULL
A	NULL
.	NULL

Isolated	NULL
nuclear	NULL
RNA	NULL
was	NULL
hybridized	NULL
to	NULL
nitrocellulose	NULL
filters	NULL
containing	NULL
the	NULL
indicated	NULL
cDNAs	NULL
.	NULL

The	NULL
intensity	NULL
of	NULL
the	NULL
autoradiographic	NULL
signal	NULL
reflects	NULL
the	NULL
transcription	NULL
rate	NULL
of	NULL
the	NULL
gene	NULL
at	NULL
the	NULL
time	NULL
the	NULL
nuclei	NULL
were	NULL
isolated	NULL
.	NULL

current	NULL
centrifugal	NULL
elutriation	NULL
.	NULL

All	NULL
monoclonal	NULL
antibodies	NULL
were	NULL
obtained	NULL
from	NULL
Transduction	NULL
Laboratories	NULL
.	NULL

4G10	NULL
agarose	NULL
beads	NULL
were	NULL
purchased	NULL
from	NULL
UBI	NULL
.	NULL

Whole-cell	NULL
extracts	NULL
.	NULL

Cells	NULL
were	NULL
diluted	NULL
with	NULL
ice-cold	NULL
phosphate-buffered	NULL
saline	NULL
(	NULL
PBS	NULL
)	NULL
and	NULL
centrifuged	NULL
at	NULL
1,500	NULL
x	NULL
g	NULL
for	NULL
10	NULL
min	NULL
at	NULL
4°C	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
washed	NULL
with	NULL
PBS	NULL
and	NULL
resuspended	NULL
in	NULL
200	NULL
pl	NULL
of	NULL
lysis	NULL
buffer	NULL
(	NULL
20	NULL
mM	NULL
N-2-hydroxyethylpipera-zine-N'-2-ethanesulfonic	NULL
acid	NULL
[	NULL
HEPES	NULL
;	NULL
pH	NULL
7.4	NULL
]	NULL
,	NULL
1	NULL
mM	NULL
vanadate	NULL
,	NULL
150	NULL
mM	NULL
NaCl	NULL
,	NULL
1	NULL
%	NULL
Triton	NULL
X-100	NULL
,	NULL
1	NULL
mM	NULL
phenylmethylsulfonic	NULL
acid	NULL
,	NULL
1	NULL
mM	NULL
dithiothreitol	NULL
)	NULL
.	NULL

EMSA	NULL
.	NULL

Electrophoretic	NULL
mobility	NULL
shift	NULL
assays	NULL
(	NULL
EMSAs	NULL
)	NULL
were	NULL
performed	NULL
with	NULL
whole-cell	NULL
extracts	NULL
prepared	NULL
with	NULL
Triton-containing	NULL
buffers	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
19	NULL
,	NULL
35	NULL
)	NULL
.	NULL

Probes	NULL
,	NULL
consisting	NULL
of	NULL
the	NULL
gamma	NULL
response	NULL
region	NULL
(	NULL
GRR	NULL
)	NULL
found	NULL
within	NULL
the	NULL
promoter	NULL
of	NULL
the	NULL
FeyRI	NULL
gene	NULL
(	NULL
5	NULL
'	NULL
AGCATGTTTCAAGGATTTGAG	NULL
ATGTATITCCCAGAAAAG	NULL
3	NULL
'	NULL
)	NULL
and	NULL
the	NULL
ISRE	NULL
of	NULL
the	NULL
ISG15	NULL
gene	NULL
(	NULL
5	NULL
'	NULL
GATCC	NULL
ATGCCTCGGGAAAGGGAAACCGAAACTGAAGCC	NULL
3	NULL
'	NULL
)	NULL
,	NULL
were	NULL
end	NULL
labeled	NULL
with	NULL
polynucleotide	NULL
kinase	NULL
and	NULL
[	NULL
y-	NULL
>	NULL
°PJATP	NULL
.	NULL

Immunoprecipitations	NULL
.	NULL

Cell	NULL
lysates	NULL
(	NULL
350	NULL
pg	NULL
)	NULL
prepared	NULL
with	NULL
Triton	NULL
X-100-containing	NULL
buffers	NULL
were	NULL
incubated	NULL
with	NULL
anti-Tyk2	NULL
,	NULL
anti-Stat1	NULL
,	NULL
anti-Stat2	NULL
,	NULL
or	NULL
anti-Stat3	NULL
antiserum	NULL
for	NULL
2	NULL
h.	NULL
The	NULL
preparation	NULL
and	NULL
characterization	NULL
of	NULL
these	NULL
antiserum	NULL
have	NULL
been	NULL
previously	NULL
described	NULL
(	NULL
4	NULL
,	NULL
5	NULL
)	NULL
.	NULL

Antibodies	NULL
to	NULL
the	NULL
IFN-a/B	NULL
receptor	NULL
a	NULL
subunit	NULL
(	NULL
31	NULL
)	NULL
were	NULL
generated	NULL
against	NULL
the	NULL
extracellular	NULL
domain	NULL
by	NULL
immunizing	NULL
mice	NULL
with	NULL
CHO	NULL
cells	NULL
expressing	NULL
a	NULL
high	NULL
concentration	NULL
of	NULL
cell	NULL
surface	NULL
IFN-	NULL
@	NULL
/B	NULL
receptor	NULL
a	NULL
subunit	NULL
.	NULL

The	NULL
antibodies	NULL
were	NULL
screened	NULL
with	NULL
IFN-a/B	NULL
receptor	NULL
«	NULL
-sub-unit	NULL
fusion	NULL
protein	NULL
and	NULL
also	NULL
by	NULL
cell	NULL
surface	NULL
binding	NULL
,	NULL
using	NULL
fluorescence-activated	NULL
cell	NULL
sorter	NULL
analysis	NULL
(	NULL
4	NULL
,	NULL
5	NULL
)	NULL
.	NULL

Immune	NULL
complexes	NULL
were	NULL
collected	NULL
after	NULL
each	NULL
immunoprecipitation	NULL
on	NULL
protein	NULL
G	NULL
beads	NULL
,	NULL
resolved	NULL
by	NULL
sodium	NULL
dodecyl	NULL
sulfate-polyac-rylamide	NULL
gel	NULL
electrophoresis	NULL
(	NULL
SDS-PAGE	NULL
)	NULL
(	NULL
8	NULL
%	NULL
polyacrylamide	NULL
)	NULL
,	NULL
immunoblotted	NULL
with	NULL
monoclonal	NULL
antiphosphotyrosine	NULL
antibody	NULL
4G10	NULL
(	NULL
UBI	NULL
)	NULL
,	NULL
and	NULL
detected	NULL
by	NULL
enhanced	NULL
chemiluminescence	NULL
.	NULL

In	NULL
some	NULL
experiments	NULL
,	NULL
tyrosine-phosphorylated	NULL
proteins	NULL
were	NULL
immunoprecipitated	NULL
with	NULL
antiphosphotyrosine	NULL
antibody	NULL
(	NULL
4G10	NULL
)	NULL
coupled	NULL
to	NULL
agarose	NULL
beads	NULL
(	NULL
UBI	NULL
)	NULL
.	NULL

Immunoprecipitated	NULL
proteins	NULL
were	NULL
eluted	NULL
from	NULL
4G10	NULL
agarose	NULL
by	NULL
incubation	NULL
with	NULL
100	NULL
mM	NULL
phenylphosphate	NULL
,	NULL
and	NULL
eluted	NULL
material	NULL
was	NULL
resolved	NULL
by	NULL
SDS-PAGE	NULL
and	NULL
transferred	NULL
to	NULL
Immobilon	NULL
.	NULL

Blots	NULL
were	NULL
probed	NULL
with	NULL
monoclonal	NULL
antibodies	NULL
specific	NULL
for	NULL
either	NULL
Tyk2	NULL
,	NULL
Jak1	NULL
,	NULL
Stat1	NULL
,	NULL
Stat2	NULL
,	NULL
or	NULL
Stat3	NULL
,	NULL
all	NULL
purchased	NULL
from	NULL
Transduction	NULL
Labs	NULL
.	NULL

Measurement	NULL
of	NULL
Cell	NULL
Surface	NULL
IFNa	NULL
receptors	NULL
.	NULL

Recombinant	NULL
IFNa-2b	NULL
(	NULL
Scher-ing	NULL
Corp.	NULL
,	NULL
Kenilworth	NULL
,	NULL
N.J.	NULL
)	NULL
was	NULL
radioiodinated	NULL
to	NULL
high	NULL
specific	NULL
activity	NULL
with	NULL
Bolton	NULL
Hunter	NULL
reagent	NULL
.	NULL

Specific	NULL
activity	NULL
was	NULL
determined	NULL
by	NULL
an	NULL
antiviral	NULL
assay	NULL
.	NULL

Binding	NULL
of	NULL
cells	NULL
to	NULL
**	NULL
``	NULL
I-labeled	NULL
recombinant	NULL
IFNa-2b	NULL
was	NULL
performed	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
9	NULL
)	NULL
.	NULL

Scatchard	NULL
analysis	NULL
was	NULL
carried	NULL
out	NULL
with	NULL
bound	NULL
and	NULL
free	NULL
ligands	NULL
.	NULL

RESULTS	NULL
The	NULL
phorbol	NULL
ester	NULL
PMA	NULL
inhibits	NULL
IFN-a	NULL
«	NULL
-stimulated	NULL
early	NULL
response	NULL
genes	NULL
in	NULL
peripheral	NULL
blood	NULL
monocytes	NULL
.	NULL

Previous	NULL
studies	NULL
have	NULL
demonstrated	NULL
that	NULL
in	NULL
some	NULL
cells	NULL
,	NULL
PMA	NULL
treatment	NULL
results	NULL
in	NULL
the	NULL
inhibition	NULL
of	NULL
IFN-	NULL
«	NULL
-stimulated	NULL
54-kDa	NULL
gene	NULL
(	NULL
ISG54	NULL
)	NULL
expression	NULL
(	NULL
2	NULL
,	NULL
24	NULL
)	NULL
.	NULL

The	NULL
effects	NULL
of	NULL
PMA	NULL
were	NULL
cell	NULL
as	NULL
well	NULL
as	NULL
gene	NULL
specific	NULL
but	NULL
were	NULL
most	NULL
prominent	NULL
in	NULL
primary	NULL
fibroblasts	NULL
(	NULL
2	NULL
)	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
PMA	NULL
modulated	NULL
IFN-	NULL
«	NULL
signaling	NULL
in	NULL
other	NULL
primary	NULL
cells	NULL
,	NULL
we	NULL
examined	NULL
the	NULL
actions	NULL
of	NULL
this	NULL
growth	NULL
promoter	NULL
in	NULL
primary	NULL
human	NULL
monocytes	NULL
.	NULL

Monocytes	NULL
are	NULL
very	NULL
sensitive	NULL
to	NULL
the	NULL
effects	NULL
of	NULL
phorbol	NULL
esters	NULL
in	NULL
that	NULL
they	NULL
promote	NULL
cell	NULL
attachment	NULL
and	NULL
phagocytosis	NULL
,	NULL
both	NULL
of	NULL
which	NULL
may	NULL
modulate	NULL
the	NULL
actions	NULL
of	NULL
IFNs	NULL
.	NULL

RNA	NULL
was	NULL
prepared	NULL
from	NULL
monocytes	NULL
which	NULL
had	NULL
been	NULL
left	NULL
untreated	NULL
or	NULL
were	NULL
treated	NULL
with	NULL
PMA	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
IFN-	NULL
«	NULL
,	NULL
and	NULL
the	NULL
induction	NULL
of	NULL
several	NULL
IFN-	NULL
«	NULL
-induced	NULL
RNAs	NULL
was	NULL
analyzed	NULL
by	NULL
RNase	NULL
protection	NULL
assays	NULL
(	NULL
Fig	NULL
.	NULL

Vou	NULL
.	NULL

16	NULL
,	NULL
1996	NULL
1A	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
primary	NULL
human	NULL
fibroblasts	NULL
,	NULL
in	NULL
which	NULL
PMA	NULL
treatment	NULL
of	NULL
cells	NULL
inhibited	NULL
ISG54	NULL
but	NULL
not	NULL
ISG15	NULL
RNA	NULL
(	NULL
24	NULL
)	NULL
,	NULL
in	NULL
primary	NULL
human	NULL
monocytes	NULL
,	NULL
PMA	NULL
inhibited	NULL
IFN-e-stimulated	NULL
expression	NULL
of	NULL
several	NULL
IFN-	NULL
«	NULL
-induced	NULL
RNAs	NULL
including	NULL
ISG54	NULL
,	NULL
ISG15	NULL
,	NULL
9-27	NULL
,	NULL
and	NULL
IFN-2	NULL
.	NULL

However	NULL
,	NULL
under	NULL
the	NULL
same	NULL
conditions	NULL
,	NULL
IFN-y-stimulated	NULL
expression	NULL
of	NULL
FeyR1	NULL
RNA	NULL
was	NULL
unaffected	NULL
,	NULL
suggesting	NULL
that	NULL
the	NULL
effects	NULL
of	NULL
PMA	NULL
were	NULL
specific	NULL
for	NULL
the	NULL
IFN	NULL
«	NULL
/B	NULL
signaling	NULL
cascade	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
PMA	NULL
treatment	NULL
of	NULL
monocytes	NULL
was	NULL
affecting	NULL
IFN-o	NULL
«	NULL
-stimulated	NULL
transcription	NULL
of	NULL
these	NULL
early	NULL
response	NULL
genes	NULL
rather	NULL
than	NULL
modifying	NULL
the	NULL
RNA	NULL
half-life	NULL
,	NULL
nuclear	NULL
run-on	NULL
assays	NULL
were	NULL
performed	NULL
(	NULL
Fig	NULL
.	NULL

1C	NULL
)	NULL
.	NULL

Monocytes	NULL
were	NULL
incubated	NULL
with	NULL
PMA	NULL
for	NULL
1	NULL
h	NULL
prior	NULL
to	NULL
the	NULL
addition	NULL
of	NULL
IFN-	NULL
«	NULL
for	NULL
another	NULL
45	NULL
min	NULL
.	NULL

Nuclei	NULL
were	NULL
isolated	NULL
and	NULL
incubated	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
[	NULL
«	NULL
-	NULL
``	NULL
P	NULL
]	NULL
JUTP	NULL
,	NULL
and	NULL
isolated	NULL
nuclear	NULL
RNA	NULL
was	NULL
hybridized	NULL
to	NULL
nitrocellulose	NULL
filters	NULL
containing	NULL
the	NULL
indicated	NULL
cDNA	NULL
probes	NULL
.	NULL

The	NULL
intensity	NULL
of	NULL
the	NULL
autoradiographic	NULL
signal	NULL
is	NULL
a	NULL
reflection	NULL
of	NULL
the	NULL
transcription	NULL
rate	NULL
of	NULL
a	NULL
given	NULL
gene	NULL
at	NULL
the	NULL
time	NULL
the	NULL
nuclei	NULL
were	NULL
isolated	NULL
(	NULL
8	NULL
)	NULL
.	NULL

PMA	NULL
inhibited	NULL
by	NULL
80	NULL
to	NULL
90	NULL
%	NULL
the	NULL
transcription	NULL
of	NULL
all	NULL
IFN-	NULL
«	NULL
-stimulated	NULL
genes	NULL
examined	NULL
while	NULL
the	NULL
effects	NULL
on	NULL
actin	NULL
and	NULL
glyceraldehyde	NULL
phosphate-3-dehydrogenase	NULL
transcription	NULL
were	NULL
insignificant	NULL
(	NULL
Fig	NULL
.	NULL

1C	NULL
)	NULL
.	NULL

PMA	NULL
treatment	NULL
of	NULL
monocytes	NULL
does	NULL
not	NULL
alter	NULL
IFN-	NULL
«	NULL
binding	NULL
to	NULL
its	NULL
receptor	NULL
.	NULL

One	NULL
possible	NULL
explanation	NULL
of	NULL
the	NULL
inhibitory	NULL
actions	NULL
of	NULL
PMA	NULL
on	NULL
IFN-	NULL
«	NULL
activation	NULL
of	NULL
early	NULL
response	NULL
genes	NULL
is	NULL
that	NULL
PMA	NULL
treatment	NULL
of	NULL
monocytes	NULL
decreases	NULL
the	NULL
number	NULL
or	NULL
affinity	NULL
of	NULL
IFN-a	NULL
«	NULL
cell	NULL
surface	NULL
receptors	NULL
.	NULL

To	NULL
explore	NULL
this	NULL
possibility	NULL
,	NULL
receptor-binding	NULL
assays	NULL
were	NULL
performed	NULL
with	NULL
'**I-la-beled	NULL
IFN-	NULL
«	NULL
2b	NULL
;	NULL
and	NULL
the	NULL
receptor	NULL
number	NULL
and	NULL
affinity	NULL
were	NULL
determined	NULL
by	NULL
Scatchard	NULL
analysis	NULL
.	NULL

Peripheral	NULL
blood	NULL
monocytes	NULL
contain	NULL
approximately	NULL
625	NULL
receptors	NULL
per	NULL
cell	NULL
with	NULL
an	NULL
apparent	NULL
affinity	NULL
of	NULL
6.2	NULL
X	NULL
10	NULL
``	NULL
°	NULL
for	NULL
IFN-	NULL
«	NULL
2b	NULL
.	NULL

Incubation	NULL
of	NULL
monocytes	NULL
with	NULL
PMA	NULL
for	NULL
60	NULL
min	NULL
prior	NULL
to	NULL
performing	NULL
the	NULL
binding	NULL
assay	NULL
had	NULL
no	NULL
significant	NULL
effect	NULL
on	NULL
either	NULL
the	NULL
number	NULL
(	NULL
575	NULL
)	NULL
or	NULL
affinity	NULL
(	NULL
7.1	NULL
x	NULL
10	NULL
``	NULL
)	NULL
of	NULL
IFN-	NULL
«	NULL
receptors	NULL
for	NULL
their	NULL
ligand	NULL
.	NULL

These	NULL
results	NULL
rule	NULL
out	NULL
the	NULL
possibility	NULL
that	NULL
a	NULL
simple	NULL
change	NULL
in	NULL
IFN-	NULL
«	NULL
cell	NULL
surface	NULL
receptors	NULL
can	NULL
account	NULL
for	NULL
the	NULL
inhibitory	NULL
actions	NULL
of	NULL
PMA	NULL
.	NULL

IFN-a	NULL
@	NULL
-induced	NULL
formation	NULL
of	NULL
ISGF3	NULL
and	NULL
complexes	NULL
that	NULL
bind	NULL
GAS	NULL
enhancers	NULL
are	NULL
decreased	NULL
in	NULL
PMA-treated	NULL
monocytes	NULL
.	NULL

Five	NULL
of	NULL
the	NULL
signaling	NULL
components	NULL
besides	NULL
the	NULL
receptor	NULL
that	NULL
are	NULL
required	NULL
for	NULL
IFN-	NULL
«	NULL
/B	NULL
activation	NULL
of	NULL
early	NULL
response	NULL
genes	NULL
include	NULL
the	NULL
tyrosine	NULL
kinases	NULL
Tyk2	NULL
and	NULL
Jak1	NULL
and	NULL
the	NULL
transcription	NULL
factors	NULL
Stat1	NULL
,	NULL
Stat2	NULL
,	NULL
and	NULL
Stat3	NULL
.	NULL

Each	NULL
of	NULL
these	NULL
proteins	NULL
is	NULL
rapidly	NULL
tyrosine	NULL
phosphorylated	NULL
as	NULL
a	NULL
result	NULL
of	NULL
IFN-	NULL
«	NULL
/B	NULL
binding	NULL
to	NULL
its	NULL
receptor	NULL
.	NULL

Tyrosine	NULL
phosphorylation	NULL
of	NULL
the	NULL
Stat	NULL
proteins	NULL
allows	NULL
them	NULL
to	NULL
form	NULL
dimers	NULL
and	NULL
translocate	NULL
to	NULL
the	NULL
nucleus	NULL
,	NULL
where	NULL
they	NULL
bind	NULL
to	NULL
specific	NULL
enhancers	NULL
(	NULL
GAS	NULL
and	NULL
ISRE	NULL
)	NULL
within	NULL
the	NULL
promoters	NULL
of	NULL
IFN-	NULL
«	NULL
/B-activated	NULL
genes	NULL
(	NULL
20	NULL
)	NULL
.	NULL

While	NULL
Stat1	NULL
and	NULL
Stat3	NULL
bind	NULL
to	NULL
both	NULL
GAS-like	NULL
and	NULL
ISRE	NULL
enhancers	NULL
,	NULL
Stat2	NULL
binds	NULL
only	NULL
to	NULL
the	NULL
ISRE	NULL
(	NULL
20	NULL
)	NULL
.	NULL

To	NULL
initially	NULL
determine	NULL
whether	NULL
PMA	NULL
inhibited	NULL
IFN-	NULL
«	NULL
/B-stimulated	NULL
binding	NULL
to	NULL
the	NULL
GAS	NULL
and	NULL
ISRE	NULL
enhancers	NULL
,	NULL
EMSAs	NULL
were	NULL
performed	NULL
with	NULL
oligonucleotide	NULL
probes	NULL
corresponding	NULL
to	NULL
the	NULL
ISRE	NULL
of	NULL
the	NULL
ISG15	NULL
gene	NULL
and	NULL
the	NULL
GRR	NULL
of	NULL
the	NULL
FeyR1	NULL
enhancer	NULL
.	NULL

PMA	NULL
treatment	NULL
of	NULL
monocytes	NULL
prior	NULL
to	NULL
the	NULL
addition	NULL
of	NULL
IFN-	NULL
«	NULL
clearly	NULL
inhibited	NULL
formation	NULL
of	NULL
the	NULL
IFN-	NULL
«	NULL
-induced	NULL
complex	NULL
which	NULL
bound	NULL
to	NULL
the	NULL
GRR	NULL
(	NULL
Fig	NULL
.	NULL

2A	NULL
)	NULL
and	NULL
also	NULL
formation	NULL
of	NULL
the	NULL
ISGF3	NULL
transcription	NULL
complex	NULL
that	NULL
bound	NULL
to	NULL
the	NULL
ISRE	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
.	NULL

This	NULL
finding	NULL
excluded	NULL
ISGF3qy	NULL
as	NULL
the	NULL
primary	NULL
target	NULL
for	NULL
PMA	NULL
,	NULL
because	NULL
ISGF3y	NULL
is	NULL
required	NULL
for	NULL
the	NULL
formation	NULL
of	NULL
ISGF3	NULL
but	NULL
not	NULL
for	NULL
the	NULL
GRR-binding	NULL
complex	NULL
(	NULL
14	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
IFN-y-induced	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
Statl	NULL
and	NULL
its	NULL
binding	NULL
to	NULL
the	NULL
GRR	NULL
were	NULL
not	NULL
affected	NULL
by	NULL
PMA	NULL
treatment	NULL
of	NULL
the	NULL
same	NULL
monocytes	NULL
(	NULL
Fig	NULL
.	NULL

2A	NULL
,	NULL
lanes	NULL
6	NULL
and	NULL
7	NULL
)	NULL
.	NULL

IFN-a	NULL
«	NULL
-stimulated	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
Statla	NULL
,	NULL
Stat2	NULL
,	NULL
and	NULL
Stat3	NULL
is	NULL
inhibited	NULL
in	NULL
monocytes	NULL
incubated	NULL
with	NULL
PMA	NULL
.	NULL

To	NULL
examine	NULL
directly	NULL
whether	NULL
PMA	NULL
treatment	NULL
of	NULL
monocytes	NULL
affected	NULL
IFN-	NULL
«	NULL
-stimulated	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
INHIBITION	NULL
OF	NULL
IFN-	NULL
«	NULL
TRANSDUCTION	NULL
1421	NULL
A	NULL
B	NULL
e	NULL
]	NULL
a	NULL
a	NULL
5	NULL
2	NULL
Z	NULL
z	NULL
2	NULL
&	NULL
&	NULL
&	NULL
&	NULL
3	NULL
<	NULL
s	NULL
igo	NULL
p	NULL
g	NULL
<	NULL
3	NULL
i	NULL
<	NULL
-	NULL
hoZ	NULL
3	NULL
2	NULL
3	NULL
2	NULL
3	NULL
z	NULL
hoZ	NULL
3	NULL
z	NULL
o	NULL
&	NULL
A	NULL
&	NULL
&	NULL
&	NULL
&	NULL
a	NULL
a	NULL
o	NULL
L	NULL
a	NULL
a	NULL
ISGF3	NULL
-	NULL
»	NULL
(	NULL
ot	NULL
GRR-BP	NULL
-	NULL
»	NULL
d	NULL
l	NULL
u	NULL
i	NULL
‘	NULL
“	NULL
‘	NULL
~~v	NULL
|	NULL
#	NULL
is	NULL
1o	NULL
2	NULL
8	NULL
4	NULL
50	NULL
6	NULL
7	NULL
8	NULL
102	NULL
3	NULL
4	NULL
FIG	NULL
.	NULL

2	NULL
.	NULL

Incubation	NULL
of	NULL
monocytes	NULL
with	NULL
PMA	NULL
inhibits	NULL
IFN-	NULL
«	NULL
-induced	NULL
DNA	NULL
binding	NULL
to	NULL
the	NULL
GRR	NULL
of	NULL
the	NULL
high-affinity	NULL
FeyR1	NULL
enhancer	NULL
and	NULL
to	NULL
the	NULL
ISRE	NULL
.	NULL

Peripheral	NULL
blood	NULL
monocytes	NULL
were	NULL
incubated	NULL
with	NULL
PMA	NULL
as	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
for	NULL
1	NULL
h	NULL
prior	NULL
to	NULL
the	NULL
addition	NULL
of	NULL
either	NULL
IFN-	NULL
«	NULL
,	NULL
IFN-B	NULL
,	NULL
or	NULL
IFN-y	NULL
for	NULL
15	NULL
min	NULL
.	NULL

Whole-cell	NULL
extracts	NULL
were	NULL
prepared	NULL
,	NULL
and	NULL
EMSAs	NULL
were	NULL
performed	NULL
to	NULL
assay	NULL
for	NULL
binding	NULL
to	NULL
the	NULL
GRR	NULL
enhancer	NULL
(	NULL
A	NULL
)	NULL
or	NULL
for	NULL
ISGF3	NULL
formation	NULL
(	NULL
B	NULL
)	NULL
by	NULL
using	NULL
a	NULL
probe	NULL
corresponding	NULL
to	NULL
the	NULL
ISRE	NULL
of	NULL
the	NULL
ISG15	NULL
gene	NULL
(	NULL
24	NULL
)	NULL
.	NULL

Samples	NULL
treated	NULL
with	NULL
only	NULL
PMA	NULL
were	NULL
incubated	NULL
for	NULL
a	NULL
total	NULL
of	NULL
75	NULL
min	NULL
.	NULL

CTL	NULL
,	NULL
control	NULL
.	NULL

GRR-BP	NULL
indicates	NULL
the	NULL
IFN-induced	NULL
complex	NULL
which	NULL
binds	NULL
to	NULL
the	NULL
GRR	NULL
.	NULL

the	NULL
Stat	NULL
proteins	NULL
,	NULL
monocytes	NULL
were	NULL
incubated	NULL
with	NULL
or	NULL
without	NULL
PMA	NULL
prior	NULL
to	NULL
the	NULL
addition	NULL
of	NULL
IFN-	NULL
«	NULL
for	NULL
30	NULL
min	NULL
.	NULL

Cell	NULL
lysates	NULL
were	NULL
prepared	NULL
and	NULL
immunoprecipitated	NULL
with	NULL
antiserum	NULL
specific	NULL
for	NULL
Statla	NULL
,	NULL
Stat2	NULL
,	NULL
or	NULL
Stat3	NULL
.	NULL

Immunoprecipitated	NULL
proteins	NULL
were	NULL
resolved	NULL
by	NULL
SDS-PAGE	NULL
and	NULL
transferred	NULL
to	NULL
Immobilon	NULL
.	NULL

Immunoblotting	NULL
was	NULL
then	NULL
performed	NULL
with	NULL
antiphosphotyrosine	NULL
antibodies	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

PMA	NULL
treatment	NULL
of	NULL
monocytes	NULL
inhibited	NULL
A	NULL
B	NULL
STAT	NULL
STATZ2	NULL
2	NULL
5	NULL
23s	NULL
U	NULL
5	NULL
as	NULL
2	NULL
5	NULL
E	NULL
EE	NULL
5	NULL
&	NULL
FE	NULL
STAT2	NULL
-	NULL
»	NULL
%	NULL
STAT	NULL
-	NULL
»	NULL
woe	NULL
ote	NULL
«	NULL
wae	NULL
*	NULL
wn	NULL
coe	NULL
mut	NULL
suse	NULL
l	NULL
1-2	NULL
3	NULL
e	NULL
STAT3	NULL
STAT	NULL
a_	NULL
S	NULL
is	NULL
a	NULL
&	NULL
€	NULL
>	NULL
5	NULL
E	NULL
FE	NULL
5	NULL
&	NULL
ZE	NULL
STATN	NULL
-	NULL
»	NULL
we	NULL
<	NULL
<	NULL
STAT3	NULL
-	NULL
»	NULL
j	NULL
10203	NULL
FIG	NULL
.	NULL

3	NULL
.	NULL

Incubation	NULL
of	NULL
monocytes	NULL
with	NULL
PMA	NULL
inhibits	NULL
IFN-	NULL
«	NULL
-stimulated	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
Statle	NULL
,	NULL
Stat2	NULL
,	NULL
and	NULL
Stat3	NULL
.	NULL

Peripheral	NULL
blood	NULL
monocytes	NULL
were	NULL
incubated	NULL
with	NULL
or	NULL
without	NULL
PMA	NULL
for	NULL
1	NULL
h	NULL
prior	NULL
to	NULL
the	NULL
addition	NULL
of	NULL
IFN-	NULL
«	NULL
or	NULL
IFN-y	NULL
for	NULL
30	NULL
min	NULL
as	NULL
described	NULL
in	NULL
the	NULL
legend	NULL
to	NULL
Fig	NULL
.	NULL

2	NULL
.	NULL

Cell	NULL
extracts	NULL
were	NULL
prepared	NULL
,	NULL
and	NULL
Statle	NULL
(	NULL
A	NULL
)	NULL
,	NULL
Stat2	NULL
(	NULL
B	NULL
)	NULL
,	NULL
and	NULL
Stat3	NULL
(	NULL
C	NULL
)	NULL
were	NULL
immunoprecipitated	NULL
from	NULL
the	NULL
extracts	NULL
,	NULL
resolved	NULL
by	NULL
SDS-PAGE	NULL
,	NULL
and	NULL
transferred	NULL
to	NULL
Immobilon	NULL
.	NULL

For	NULL
samples	NULL
treated	NULL
with	NULL
IFN-y	NULL
only	NULL
(	NULL
D	NULL
)	NULL
,	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
Statl	NULL
was	NULL
analyzed	NULL
,	NULL
since	NULL
this	NULL
is	NULL
the	NULL
primary	NULL
or	NULL
only	NULL
Stat	NULL
activated	NULL
by	NULL
this	NULL
cytokine	NULL
.	NULL

The	NULL
resulting	NULL
blots	NULL
were	NULL
probed	NULL
with	NULL
4G10	NULL
antiphosphotyrosine	NULL
antibody	NULL
.	NULL

CTL	NULL
,	NULL
control	NULL
.	NULL

1422	NULL
PETRICOIN	NULL
ET	NULL
AL	NULL
.	NULL

A	NULL
JAK1	NULL
CTL	NULL
IFN	NULL
PMA/	NULL
IFN	NULL
JAK1	NULL
-	NULL
»	NULL
TYK2	NULL
-	NULL
»	NULL
1°	NULL
2	NULL
3	NULL
TYK2	NULL
CTL	NULL
1	NULL
Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

IFNaR	NULL
5	NULL
4	NULL
&	NULL
3	NULL
2	NULL
5	NULL
<	NULL
3	NULL
&	NULL
FE	NULL
5	NULL
&	NULL
FE	NULL
|FNaR	NULL
-	NULL
»	NULL
$	NULL
wa	NULL
«	NULL
@	NULL
2	NULL
3	NULL
1	NULL
2	NULL
3	NULL
FIG	NULL
.	NULL

4	NULL
.	NULL

Incubation	NULL
of	NULL
monocytes	NULL
with	NULL
PMA	NULL
inhibits	NULL
IFN-	NULL
«	NULL
-stimulated	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
Tyk2	NULL
but	NULL
not	NULL
of	NULL
Jak1	NULL
or	NULL
the	NULL
a	NULL
subunit	NULL
of	NULL
the	NULL
IFN-	NULL
«	NULL
/f	NULL
receptor	NULL
(	NULL
IFNaR	NULL
)	NULL
.	NULL

Peripheral	NULL
blood	NULL
monocytes	NULL
were	NULL
incubated	NULL
as	NULL
described	NULL
in	NULL
the	NULL
legend	NULL
to	NULL
Fig	NULL
.	NULL

2	NULL
,	NULL
and	NULL
cell	NULL
extracts	NULL
were	NULL
prepared	NULL
.	NULL

(	NULL
A	NULL
and	NULL
B	NULL
)	NULL
The	NULL
extracts	NULL
were	NULL
subjected	NULL
to	NULL
immunoprecipitation	NULL
with	NULL
4G10	NULL
antiphosphotyrosine	NULL
antibody	NULL
,	NULL
and	NULL
the	NULL
subsequent	NULL
blots	NULL
were	NULL
probed	NULL
for	NULL
the	NULL
presence	NULL
of	NULL
either	NULL
Jak1	NULL
(	NULL
A	NULL
)	NULL
or	NULL
Tyk2	NULL
(	NULL
B	NULL
)	NULL
.	NULL

(	NULL
C	NULL
)	NULL
The	NULL
extracts	NULL
were	NULL
directly	NULL
precipitated	NULL
with	NULL
monoclonal	NULL
antibody	NULL
to	NULL
the	NULL
«	NULL
subunit	NULL
of	NULL
the	NULL
IFN-	NULL
«	NULL
/B	NULL
receptor	NULL
,	NULL
and	NULL
the	NULL
resulting	NULL
blot	NULL
was	NULL
probed	NULL
with	NULL
antiphosphotyrosine	NULL
antibody	NULL
(	NULL
4G10	NULL
)	NULL
.	NULL

IFN-	NULL
«	NULL
-stimulated	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
all	NULL
three	NULL
Stat	NULL
proteins	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
,	NULL
whereas	NULL
IFN-y	NULL
activation	NULL
of	NULL
was	NULL
not	NULL
affected	NULL
(	NULL
Fig	NULL
.	NULL

3D	NULL
)	NULL
.	NULL

The	NULL
blots	NULL
were	NULL
reprobed	NULL
with	NULL
their	NULL
respective	NULL
Stat-specific	NULL
antisera	NULL
to	NULL
ensure	NULL
that	NULL
equal	NULL
amounts	NULL
of	NULL
Stat	NULL
protein	NULL
were	NULL
present	NULL
in	NULL
each	NULL
sample	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

PMA	NULL
inhibits	NULL
IFNa-stimulated	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
Tyk2	NULL
but	NULL
not	NULL
Jak	NULL
]	NULL
and	NULL
the	NULL
«	NULL
subunit	NULL
of	NULL
the	NULL
IFN-	NULL
«	NULL
@	NULL
/f	NULL
receptor	NULL
.	NULL

The	NULL
observation	NULL
that	NULL
PMA	NULL
inhibited	NULL
IFN-	NULL
«	NULL
-stimulated	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
Statla	NULL
,	NULL
Stat2	NULL
,	NULL
and	NULL
Stat3	NULL
suggested	NULL
that	NULL
it	NULL
affects	NULL
a	NULL
signaling	NULL
component	NULL
(	NULL
s	NULL
)	NULL
upstream	NULL
of	NULL
these	NULL
transcription	NULL
factors	NULL
.	NULL

Both	NULL
the	NULL
Tyk2	NULL
and	NULL
Jak1	NULL
tyrosine	NULL
kinases	NULL
are	NULL
required	NULL
for	NULL
IFN-	NULL
«	NULL
-stimulated	NULL
gene	NULL
expression	NULL
,	NULL
and	NULL
activation	NULL
of	NULL
these	NULL
kinases	NULL
by	NULL
IFN-	NULL
«	NULL
treatment	NULL
of	NULL
cells	NULL
induces	NULL
their	NULL
tyrosine	NULL
phosphorylation	NULL
(	NULL
22	NULL
,	NULL
33	NULL
)	NULL
.	NULL

To	NULL
examine	NULL
whether	NULL
PMA	NULL
affected	NULL
IFN-	NULL
«	NULL
-induced	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
Tyk2	NULL
and	NULL
Jak1	NULL
,	NULL
we	NULL
incubated	NULL
monocytes	NULL
with	NULL
or	NULL
without	NULL
PMA	NULL
for	NULL
30	NULL
min	NULL
prior	NULL
to	NULL
the	NULL
addition	NULL
of	NULL
IFN-	NULL
«	NULL
for	NULL
10	NULL
min	NULL
.	NULL

Cell	NULL
lysates	NULL
were	NULL
prepared	NULL
and	NULL
incubated	NULL
with	NULL
antiphosphotyrosine	NULL
antibody	NULL
.	NULL

Immunoprecipitated	NULL
proteins	NULL
were	NULL
resolved	NULL
by	NULL
SDS-PAGE	NULL
,	NULL
blotted	NULL
,	NULL
and	NULL
probed	NULL
for	NULL
the	NULL
presence	NULL
of	NULL
either	NULL
Tyk2	NULL
or	NULL
Jakl	NULL
(	NULL
Fig	NULL
.	NULL

4A	NULL
and	NULL
B	NULL
)	NULL
.	NULL

Although	NULL
IFN-	NULL
«	NULL
-stimulated	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
Jak1	NULL
was	NULL
unaffected	NULL
by	NULL
treatment	NULL
with	NULL
PMA	NULL
,	NULL
there	NULL
was	NULL
virtually	NULL
complete	NULL
inhibition	NULL
of	NULL
IFN-	NULL
«	NULL
-induced	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
Tyk2	NULL
.	NULL

Direct	NULL
immunoprecipitations	NULL
of	NULL
Jak1	NULL
and	NULL
Tyk2	NULL
followed	NULL
by	NULL
antiphosphotyrosine	NULL
blotting	NULL
revealed	NULL
similar	NULL
results	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
a	NULL
subunit	NULL
of	NULL
the	NULL
IFN	NULL
«	NULL
/B	NULL
receptor	NULL
has	NULL
also	NULL
been	NULL
demonstrated	NULL
to	NULL
be	NULL
rapidly	NULL
tyrosine	NULL
phosphorylated	NULL
as	NULL
a	NULL
result	NULL
of	NULL
exposure	NULL
of	NULL
cells	NULL
to	NULL
IFN-	NULL
«	NULL
or	NULL
IFN-B	NULL
(	NULL
26	NULL
)	NULL
.	NULL

Since	NULL
Tyk2	NULL
but	NULL
not	NULL
Jak1	NULL
appeared	NULL
to	NULL
be	NULL
a	NULL
target	NULL
for	NULL
the	NULL
PMA-induced	NULL
inhibition	NULL
of	NULL
this	NULL
signaling	NULL
cascade	NULL
,	NULL
this	NULL
observation	NULL
allowed	NULL
us	NULL
to	NULL
examine	NULL
whether	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
the	NULL
a	NULL
subunit	NULL
of	NULL
the	NULL
receptor	NULL
paralleled	NULL
the	NULL
actions	NULL
of	NULL
PMA	NULL
with	NULL
regard	NULL
to	NULL
Tyk2	NULL
.	NULL

Monocytes	NULL
were	NULL
incubated	NULL
with	NULL
PMA	NULL
(	NULL
Fig	NULL
.	NULL

4A	NULL
and	NULL
B	NULL
)	NULL
,	NULL
and	NULL
extracts	NULL
were	NULL
immunoprecipitated	NULL
with	NULL
a	NULL
monoclonal	NULL
antibody	NULL
to	NULL
the	NULL
a	NULL
subunit	NULL
of	NULL
the	NULL
IFN-	NULL
«	NULL
/f	NULL
receptor	NULL
.	NULL

The	NULL
subsequent	NULL
blots	NULL
were	NULL
probed	NULL
with	NULL
antiphosphotyrosine	NULL
antibody	NULL
(	NULL
Fig	NULL
.	NULL

4C	NULL
)	NULL
.	NULL

It	NULL
is	NULL
evident	NULL
from	NULL
these	NULL
results	NULL
that	NULL
while	NULL
IFN-	NULL
«	NULL
induced	NULL
the	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
this	NULL
subunit	NULL
of	NULL
the	NULL
receptor	NULL
,	NULL
PMA	NULL
had	NULL
no	NULL
inhibitory	NULL
effect	NULL
on	NULL
this	NULL
event	NULL
.	NULL

This	NULL
finding	NULL
suggested	NULL
that	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
the	NULL
«	NULL
subunit	NULL
of	NULL
the	NULL
receptor	NULL
in	NULL
primary	NULL
monocytes	NULL
may	NULL
be	NULL
more	NULL
directly	NULL
linked	NULL
to	NULL
activation	NULL
of	NULL
Jak	NULL
]	NULL
rather	NULL
than	NULL
of	NULL
Tyk2	NULL
.	NULL

Evidence	NULL
for	NULL
the	NULL
role	NULL
of	NULL
a	NULL
PMA-activated	NULL
tyrosine	NULL
phosphatase	NULL
which	NULL
targets	NULL
phosphorylated	NULL
Tyk2	NULL
.	NULL

From	NULL
the	NULL
results	NULL
presented	NULL
above	NULL
,	NULL
it	NULL
appeared	NULL
that	NULL
PMA	NULL
treatment	NULL
of	NULL
peripheral	NULL
blood	NULL
monocytes	NULL
selectively	NULL
inhibited	NULL
IFN-	NULL
«	NULL
-stimulated	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
Tyk2	NULL
.	NULL

Two	NULL
possible	NULL
mechanisms	NULL
could	NULL
account	NULL
for	NULL
the	NULL
actions	NULL
of	NULL
PMA	NULL
.	NULL

Either	NULL
PMA	NULL
treatment	NULL
of	NULL
monocytes	NULL
inactivates	NULL
the	NULL
kinase	NULL
which	NULL
is	NULL
responsible	NULL
for	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
Tyk2	NULL
,	NULL
or	NULL
PMA	NULL
activates	NULL
a	NULL
tyrosine	NULL
phosphatase	NULL
(	NULL
protein	NULL
tyrosine	NULL
phosphatase	NULL
[	NULL
PTPase	NULL
]	NULL
)	NULL
which	NULL
dephosphorylates	NULL
this	NULL
kinase	NULL
.	NULL

If	NULL
a	NULL
tyrosine	NULL
phosphatase	NULL
were	NULL
activated	NULL
by	NULL
PMA	NULL
treatment	NULL
of	NULL
monocytes	NULL
,	NULL
incubation	NULL
of	NULL
cells	NULL
with	NULL
the	NULL
tyrosine	NULL
phosphatase	NULL
inhibitor	NULL
vanadate	NULL
should	NULL
reverse	NULL
the	NULL
inhibitory	NULL
effects	NULL
of	NULL
PMA	NULL
.	NULL

Monocytes	NULL
were	NULL
incubated	NULL
for	NULL
30	NULL
min	NULL
with	NULL
vanadate	NULL
prior	NULL
to	NULL
the	NULL
addition	NULL
of	NULL
PMA	NULL
for	NULL
30	NULL
min	NULL
.	NULL

IFN-a	NULL
«	NULL
was	NULL
then	NULL
added	NULL
to	NULL
the	NULL
cells	NULL
for	NULL
a	NULL
further	NULL
15	NULL
min	NULL
prior	NULL
to	NULL
the	NULL
preparation	NULL
of	NULL
cell	NULL
extracts	NULL
.	NULL

EMSAs	NULL
were	NULL
performed	NULL
with	NULL
the	NULL
GRR	NULL
enhancer	NULL
,	NULL
or	NULL
antiphosphotyrosine	NULL
immunoprecipitates	NULL
were	NULL
probed	NULL
for	NULL
Tyk2	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

Preincubation	NULL
of	NULL
monocytes	NULL
with	NULL
vanadate	NULL
prevented	NULL
most	NULL
of	NULL
the	NULL
inhibition	NULL
by	NULL
PMA	NULL
of	NULL
IFN-a-stimulated	NULL
formation	NULL
of	NULL
the	NULL
GRR-binding	NULL
complex	NULL
(	NULL
Fig	NULL
.	NULL

5A	NULL
,	NULL
lanes	NULL
2	NULL
and	NULL
6	NULL
)	NULL
.	NULL

In	NULL
other	NULL
experiments	NULL
,	NULL
vanadate	NULL
completely	NULL
blocked	NULL
the	NULL
actions	NULL
of	NULL
PMA	NULL
and	NULL
also	NULL
enabled	NULL
Tyk2	NULL
to	NULL
be	NULL
tyrosine	NULL
phosphorylated	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
PMA	NULL
and	NULL
IFN-	NULL
«	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
,	NULL
lanes	NULL
5	NULL
,	NULL
6	NULL
,	NULL
and	NULL
8	NULL
)	NULL
.	NULL

Vanadate	NULL
treatment	NULL
of	NULL
cells	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
PMA	NULL
or	NULL
IFN-	NULL
«	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
either	NULL
formation	NULL
of	NULL
the	NULL
GRR-binding	NULL
complex	NULL
(	NULL
Fig	NULL
.	NULL

5A	NULL
,	NULL
lane	NULL
5	NULL
)	NULL
or	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
Tyk2	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
,	NULL
lane	NULL
3	NULL
)	NULL
.	NULL

If	NULL
the	NULL
inhibitory	NULL
actions	NULL
of	NULL
PMA	NULL
were	NULL
mediated	NULL
through	NULL
the	NULL
activation	NULL
of	NULL
a	NULL
tyrosine	NULL
phosphatase	NULL
which	NULL
targeted	NULL
Tyk2	NULL
spe-cifically	NULL
,	NULL
PMA	NULL
treatment	NULL
of	NULL
cells	NULL
should	NULL
also	NULL
stimulate	NULL
the	NULL
dephosphorylation	NULL
of	NULL
Tyk2	NULL
that	NULL
is	NULL
already	NULL
tyrosine	NULL
phosphorylated	NULL
after	NULL
IFN-	NULL
«	NULL
treatment	NULL
.	NULL

To	NULL
address	NULL
this	NULL
possibility	NULL
,	NULL
we	NULL
incubated	NULL
monocytes	NULL
with	NULL
IFN-	NULL
«	NULL
for	NULL
10	NULL
min	NULL
to	NULL
allow	NULL
Tyk2	NULL
to	NULL
become	NULL
tyrosine	NULL
phosphorylated	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
,	NULL
lane	NULL
5	NULL
)	NULL
.	NULL

PMA	NULL
was	NULL
then	NULL
added	NULL
to	NULL
the	NULL
cells	NULL
in	NULL
the	NULL
continuous	NULL
presence	NULL
of	NULL
IFN-a	NULL
«	NULL
for	NULL
an	NULL
additional	NULL
10	NULL
min	NULL
prior	NULL
to	NULL
preparation	NULL
of	NULL
cell	NULL
lysates	NULL
.	NULL

Addition	NULL
of	NULL
PMA	NULL
to	NULL
cells	NULL
which	NULL
had	NULL
previously	NULL
been	NULL
exposed	NULL
to	NULL
IFN-	NULL
«	NULL
induced	NULL
the	NULL
dephosphorylation	NULL
of	NULL
Tyk2	NULL
on	NULL
tyrosine	NULL
(	NULL
compare	NULL
lanes	NULL
5	NULL
and	NULL
7	NULL
)	NULL
,	NULL
as	NULL
did	NULL
the	NULL
addition	NULL
of	NULL
PMA	NULL
prior	NULL
to	NULL
IFN-a	NULL
(	NULL
lane	NULL
6	NULL
)	NULL
.	NULL

In	NULL
a	NULL
separate	NULL
aliquot	NULL
from	NULL
these	NULL
samples	NULL
,	NULL
Tyk2	NULL
was	NULL
directly	NULL
immunoprecipitated	NULL
and	NULL
probed	NULL
for	NULL
Tyk2	NULL
by	NULL
an	NULL
immunoblot	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
,	NULL
lower	NULL
panel	NULL
)	NULL
.	NULL

Equal	NULL
amounts	NULL
of	NULL
Tyk2	NULL
protein	NULL
were	NULL
present	NULL
in	NULL
all	NULL
samples	NULL
,	NULL
ruling	NULL
out	NULL
the	NULL
possibility	NULL
Vou	NULL
.	NULL

16	NULL
,	NULL
1996	NULL
PMA-	NULL
>	NULL
IFNa	NULL
VAN-	NULL
>	NULL
PMA-	NULL
»	NULL
IFNa	NULL
VAN-	NULL
>	NULL
PMA	NULL
VAN-	NULL
>	NULL
IFNa	NULL
PMA	NULL
VAN	NULL
5	NULL
2	NULL
z	NULL
o	NULL
&	NULL
GRR-BP	NULL
-	NULL
»	NULL
INHIBITION	NULL
OF	NULL
IFN-	NULL
«	NULL
TRANSDUCTION	NULL
1423	NULL
-PY	NULL
<	NULL
$	NULL
Z	NULL
C	NULL
A	NULL
A	NULL
5	NULL
<	NULL
&	NULL
s	NULL
a	NULL
S	NULL
2	NULL
s	NULL
2	NULL
2	NULL
$	NULL
a	NULL
.	NULL

4	NULL
0	NULL
i	NULL
&	NULL
a	NULL
Ao	NULL
}	NULL
4	NULL
8	NULL
1	NULL
1	NULL
4	NULL
a	NULL
g	NULL
z	NULL
z	NULL
9	NULL
z	NULL
z	NULL
z	NULL
hos	NULL
<	NULL
3	NULL
2	NULL
5	NULL
£	NULL
S	NULL
$	NULL
Ss	NULL
E	NULL
f	NULL
&	NULL
S	NULL
$	NULL
S	NULL
$	NULL
S	NULL
TYK2	NULL
-	NULL
»	NULL
*	NULL
``	NULL
®	NULL
@	NULL
o-TYK2	NULL
aas	NULL
ae	NULL
wilh	NULL
wo	NULL
come	NULL
wus	NULL
an	NULL
with	NULL
«	NULL
ite	NULL
cee	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
FIG	NULL
.	NULL

5	NULL
.	NULL

PMA	NULL
stimulates	NULL
a	NULL
PTPase	NULL
activity	NULL
in	NULL
monocytes	NULL
which	NULL
targets	NULL
Tyk2	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Vanadate	NULL
reverses	NULL
PMA	NULL
inhibition	NULL
of	NULL
IFN-	NULL
«	NULL
-stimulated	NULL
binding	NULL
to	NULL
the	NULL
GRR	NULL
enhancer	NULL
.	NULL

Monocytes	NULL
were	NULL
incubated	NULL
with	NULL
1	NULL
mM	NULL
vanadate	NULL
at	NULL
22°C	NULL
(	NULL
lanes	NULL
5	NULL
through	NULL
8	NULL
)	NULL
for	NULL
30	NULL
min	NULL
.	NULL

PMA	NULL
(	NULL
lanes	NULL
3	NULL
,	NULL
4	NULL
,	NULL
6	NULL
,	NULL
and	NULL
7	NULL
)	NULL
was	NULL
then	NULL
added	NULL
to	NULL
some	NULL
samples	NULL
,	NULL
and	NULL
all	NULL
samples	NULL
were	NULL
incubated	NULL
at	NULL
37°C	NULL
for	NULL
1	NULL
h.	NULL
IFN-	NULL
«	NULL
(	NULL
lanes	NULL
2	NULL
,	NULL
3	NULL
,	NULL
6	NULL
,	NULL
and	NULL
8	NULL
)	NULL
was	NULL
then	NULL
added	NULL
for	NULL
15	NULL
min	NULL
,	NULL
cell	NULL
extracts	NULL
were	NULL
prepared	NULL
,	NULL
and	NULL
EMSAs	NULL
were	NULL
performed	NULL
with	NULL
the	NULL
GRR	NULL
oligonucleotide	NULL
probe	NULL
as	NULL
described	NULL
in	NULL
the	NULL
legend	NULL
to	NULL
Fig	NULL
.	NULL

2	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Vanadate	NULL
reverses	NULL
PMA	NULL
inhibition	NULL
of	NULL
IFN-a-stimulated	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
Tyk2	NULL
,	NULL
and	NULL
PMA	NULL
stimulates	NULL
the	NULL
dephosphorylation	NULL
of	NULL
tyrosine-phosphorylated	NULL
Tyk2	NULL
.	NULL

Monocytes	NULL
were	NULL
incubated	NULL
with	NULL
vanadate	NULL
,	NULL
PMA	NULL
,	NULL
and/or	NULL
IFN-	NULL
«	NULL
as	NULL
in	NULL
panel	NULL
A	NULL
.	NULL

The	NULL
incubation	NULL
time	NULL
with	NULL
IFN-	NULL
«	NULL
was	NULL
20	NULL
min	NULL
.	NULL

In	NULL
lane	NULL
7	NULL
,	NULL
PMA	NULL
was	NULL
added	NULL
to	NULL
the	NULL
culture	NULL
10	NULL
min	NULL
after	NULL
IFN-	NULL
«	NULL
and	NULL
the	NULL
incubation	NULL
with	NULL
both	NULL
reagents	NULL
was	NULL
continued	NULL
for	NULL
an	NULL
additional	NULL
10	NULL
min	NULL
.	NULL

After	NULL
the	NULL
indicated	NULL
treatments	NULL
,	NULL
cell	NULL
extracts	NULL
were	NULL
prepared	NULL
and	NULL
immunoprecipitated	NULL
with	NULL
4G10	NULL
antiphosphotyrosine	NULL
antibody	NULL
(	NULL
«	NULL
-PY	NULL
)	NULL
.	NULL

The	NULL
resulting	NULL
blot	NULL
was	NULL
probed	NULL
with	NULL
Tyk2	NULL
monoclonal	NULL
antibody	NULL
as	NULL
in	NULL
Fig	NULL
.	NULL

4B	NULL
.	NULL

In	NULL
the	NULL
lower	NULL
part	NULL
of	NULL
panel	NULL
B	NULL
,	NULL
separate	NULL
aliquots	NULL
were	NULL
immunoprecipitated	NULL
with	NULL
anti-Tyk2	NULL
antiserum	NULL
and	NULL
the	NULL
immunoprecipitates	NULL
were	NULL
resolved	NULL
by	NULL
SDS-PAGE	NULL
.	NULL

The	NULL
resulting	NULL
blot	NULL
was	NULL
probed	NULL
for	NULL
the	NULL
presence	NULL
of	NULL
Tyk2	NULL
by	NULL
using	NULL
a	NULL
Tyk2	NULL
monoclonal	NULL
antibody	NULL
(	NULL
Transduction	NULL
Labs	NULL
)	NULL
.	NULL

that	NULL
incubation	NULL
of	NULL
monocytes	NULL
with	NULL
PMA	NULL
induced	NULL
a	NULL
selective	NULL
degradation	NULL
of	NULL
the	NULL
protein	NULL
.	NULL

Rather	NULL
,	NULL
these	NULL
results	NULL
indicate	NULL
that	NULL
PMA	NULL
is	NULL
activating	NULL
a	NULL
tyrosine	NULL
phosphatase	NULL
that	NULL
dephosphorylates	NULL
Tyk2	NULL
such	NULL
that	NULL
the	NULL
Stat	NULL
proteins	NULL
can	NULL
not	NULL
be	NULL
activated	NULL
and	NULL
transcription	NULL
of	NULL
IFN-	NULL
«	NULL
-stimulated	NULL
early	NULL
response	NULL
genes	NULL
is	NULL
blocked	NULL
.	NULL

DISCUSSION	NULL
Modulation	NULL
of	NULL
growth	NULL
factor	NULL
and	NULL
cytokine-regulated	NULL
signaling	NULL
cascades	NULL
by	NULL
viruses	NULL
and	NULL
oncogenic	NULL
proteins	NULL
is	NULL
a	NULL
well-known	NULL
phenomenon	NULL
.	NULL

For	NULL
IFN-	NULL
«	NULL
or	NULL
IFN-B	NULL
activation	NULL
of	NULL
early	NULL
response	NULL
genes	NULL
,	NULL
a	NULL
common	NULL
control	NULL
point	NULL
used	NULL
by	NULL
adenovirus	NULL
E1A	NULL
,	NULL
HPV	NULL
E6/7	NULL
,	NULL
or	NULL
phorbol	NULL
esters	NULL
is	NULL
the	NULL
disruption	NULL
of	NULL
the	NULL
interaction	NULL
of	NULL
the	NULL
48-kDa	NULL
ISRE-binding	NULL
protein	NULL
,	NULL
ISGF3y	NULL
,	NULL
with	NULL
activated	NULL
Stat	NULL
transcription	NULL
factors	NULL
(	NULL
1	NULL
,	NULL
11	NULL
,	NULL
16	NULL
)	NULL
.	NULL

The	NULL
results	NULL
of	NULL
these	NULL
studies	NULL
clearly	NULL
indicate	NULL
that	NULL
phorbol	NULL
ester	NULL
treatment	NULL
of	NULL
primary	NULL
human	NULL
peripheral	NULL
blood	NULL
monocytes	NULL
selectively	NULL
inhibits	NULL
IFN-	NULL
«	NULL
/B	NULL
activation	NULL
of	NULL
the	NULL
Jak/Stat	NULL
pathway	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
the	NULL
other	NULL
mech-anisms	NULL
,	NULL
PMA	NULL
exerts	NULL
its	NULL
inhibitory	NULL
effects	NULL
in	NULL
monocytes	NULL
by	NULL
inducing	NULL
a	NULL
tyrosine	NULL
phosphatase	NULL
activity	NULL
that	NULL
targets	NULL
Tyk2	NULL
but	NULL
has	NULL
no	NULL
effects	NULL
on	NULL
IFN-	NULL
«	NULL
-stimulated	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
either	NULL
Jak	NULL
]	NULL
or	NULL
the	NULL
a	NULL
subunit	NULL
of	NULL
the	NULL
IFN-	NULL
«	NULL
/B	NULL
receptor	NULL
.	NULL

There	NULL
is	NULL
recent	NULL
evidence	NULL
that	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
Tyk2	NULL
by	NULL
IFN-	NULL
«	NULL
treatment	NULL
of	NULL
cells	NULL
is	NULL
not	NULL
required	NULL
for	NULL
some	NULL
aspects	NULL
of	NULL
IFN	NULL
-a	NULL
signaling	NULL
(	NULL
34	NULL
)	NULL
.	NULL

That	NULL
study	NULL
showed	NULL
that	NULL
a	NULL
kinase-inactive	NULL
Tyk2	NULL
transfected	NULL
into	NULL
a	NULL
cell	NULL
line	NULL
lacking	NULL
Tyk2	NULL
could	NULL
rescue	NULL
cell	NULL
growth	NULL
under	NULL
selective	NULL
pressure	NULL
,	NULL
presumably	NULL
via	NULL
an	NULL
ISGF3-independent	NULL
pathway	NULL
.	NULL

However	NULL
,	NULL
IFN-a	NULL
«	NULL
treatment	NULL
of	NULL
cells	NULL
expressing	NULL
the	NULL
kinase-inactive	NULL
Tyk2	NULL
failed	NULL
to	NULL
stimulate	NULL
the	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
Statl	NULL
and	NULL
Stat2	NULL
(	NULL
34	NULL
)	NULL
.	NULL

These	NULL
results	NULL
are	NULL
in	NULL
agreement	NULL
with	NULL
those	NULL
presented	NULL
here	NULL
,	NULL
in	NULL
which	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
Tyk2	NULL
occurs	NULL
in	NULL
parallel	NULL
with	NULL
IFN-	NULL
«	NULL
-induced	NULL
expression	NULL
of	NULL
early	NULL
response	NULL
genes	NULL
and	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
the	NULL
Stat	NULL
proteins	NULL
.	NULL

The	NULL
mechanisms	NULL
by	NULL
which	NULL
PMA	NULL
inhibits	NULL
IFN-	NULL
«	NULL
-induced	NULL
gene	NULL
expression	NULL
by	NULL
stimulating	NULL
a	NULL
PTPase	NULL
activity	NULL
which	NULL
dephosphorylates	NULL
Tyk2	NULL
are	NULL
unresolved	NULL
.	NULL

Presumably	NULL
,	NULL
either	NULL
the	NULL
PTPase	NULL
or	NULL
a	NULL
PMA-activated	NULL
kinase	NULL
which	NULL
regulates	NULL
the	NULL
PTPase	NULL
activity	NULL
is	NULL
very	NULL
cell	NULL
specific	NULL
,	NULL
since	NULL
the	NULL
dramatic	NULL
inhibitory	NULL
actions	NULL
of	NULL
this	NULL
tumor	NULL
promoter	NULL
are	NULL
restricted	NULL
to	NULL
primary	NULL
monocytes	NULL
and	NULL
have	NULL
thus	NULL
far	NULL
not	NULL
been	NULL
observed	NULL
in	NULL
any	NULL
cell	NULL
lines	NULL
of	NULL
monocytic	NULL
origin	NULL
.	NULL

Although	NULL
it	NULL
is	NULL
still	NULL
unclear	NULL
whether	NULL
PMA	NULL
is	NULL
exerting	NULL
its	NULL
actions	NULL
by	NULL
stimulating	NULL
a	NULL
protein	NULL
kinase	NULL
C	NULL
isoform	NULL
,	NULL
we	NULL
have	NULL
observed	NULL
that	NULL
the	NULL
protein	NULL
kinase	NULL
C	NULL
inhibitor	NULL
bisin-dolylmaleimide	NULL
reverses	NULL
the	NULL
effects	NULL
of	NULL
PMA	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
a	NULL
finding	NULL
which	NULL
is	NULL
consistent	NULL
with	NULL
this	NULL
possibility	NULL
.	NULL

Previous	NULL
studies	NULL
have	NULL
implicated	NULL
the	NULL
role	NULL
of	NULL
tyrosine	NULL
phosphatases	NULL
as	NULL
both	NULL
positive	NULL
(	NULL
6	NULL
,	NULL
12	NULL
,	NULL
30	NULL
)	NULL
and	NULL
negative	NULL
(	NULL
4	NULL
,	NULL
13	NULL
)	NULL
regulators	NULL
of	NULL
IFN-	NULL
«	NULL
/	NULL
B-stimulated	NULL
activation	NULL
of	NULL
the	NULL
Jak/Stat	NULL
pathway	NULL
.	NULL

However	NULL
,	NULL
the	NULL
PMA-stimulated	NULL
PTPase	NULL
activity	NULL
described	NULL
here	NULL
appears	NULL
to	NULL
be	NULL
unique	NULL
.	NULL

Although	NULL
PTPases	NULL
are	NULL
clearly	NULL
important	NULL
modulators	NULL
of	NULL
cell	NULL
growth	NULL
and	NULL
growth	NULL
factor-mediated	NULL
signaling	NULL
cascades	NULL
,	NULL
few	NULL
instances	NULL
in	NULL
which	NULL
the	NULL
activities	NULL
of	NULL
PTPases	NULL
are	NULL
known	NULL
to	NULL
be	NULL
selective	NULL
have	NULL
been	NULL
described	NULL
.	NULL

One	NULL
such	NULL
PTPase	NULL
is	NULL
the	NULL
SHZ	NULL
domain-containing	NULL
PTPase	NULL
,	NULL
PTP1C	NULL
.	NULL

This	NULL
PTPase	NULL
has	NULL
recently	NULL
been	NULL
implicated	NULL
in	NULL
down	NULL
regulation	NULL
of	NULL
both	NULL
erythropoietin	NULL
and	NULL
IFN-	NULL
«	NULL
activation	NULL
of	NULL
Jak2	NULL
and	NULL
Jak1	NULL
,	NULL
respectively	NULL
(	NULL
4	NULL
,	NULL
18	NULL
)	NULL
.	NULL

Its	NULL
activity	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
enhanced	NULL
by	NULL
treatment	NULL
of	NULL
HL60	NULL
cells	NULL
with	NULL
phorbol	NULL
esters	NULL
(	NULL
36	NULL
)	NULL
.	NULL

PTP1C	NULL
therefore	NULL
seemed	NULL
to	NULL
be	NULL
one	NULL
candidate	NULL
for	NULL
a	NULL
PMA-stimulated	NULL
PTPase	NULL
which	NULL
could	NULL
inhibit	NULL
IFN-	NULL
«	NULL
/B-stimulated	NULL
Tyk2	NULL
activity	NULL
in	NULL
primary	NULL
monocytes	NULL
.	NULL

However	NULL
,	NULL
in	NULL
the	NULL
studies	NULL
examining	NULL
the	NULL
role	NULL
of	NULL
PTP1C	NULL
in	NULL
IFN	NULL
«	NULL
/B	NULL
activation	NULL
of	NULL
the	NULL
Jak/Stat	NULL
pathway	NULL
,	NULL
it	NULL
appears	NULL
that	NULL
this	NULL
PTPase	NULL
seems	NULL
to	NULL
selectively	NULL
inactivate	NULL
Jak1	NULL
,	NULL
with	NULL
only	NULL
modest	NULL
or	NULL
no	NULL
effects	NULL
on	NULL
IFN-	NULL
«	NULL
/B-stimulated	NULL
Tyk2	NULL
tyrosine	NULL
phosphor	NULL
1424	NULL
PETRICOIN	NULL
ET	NULL
AL	NULL
.	NULL

ylation	NULL
(	NULL
4	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
experiments	NULL
with	NULL
macrophages	NULL
from	NULL
motheaten	NULL
mice	NULL
,	NULL
which	NULL
do	NULL
not	NULL
express	NULL
PTP1C	NULL
,	NULL
indicate	NULL
that	NULL
PMA	NULL
still	NULL
is	NULL
able	NULL
to	NULL
inhibit	NULL
IFN-	NULL
«	NULL
/B	NULL
stimulation	NULL
of	NULL
the	NULL
Stat	NULL
activation	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
PTP1C	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Three	NULL
other	NULL
PTPases	NULL
which	NULL
are	NULL
regulated	NULL
by	NULL
serine	NULL
phosphorylation	NULL
and/or	NULL
PMA	NULL
treatment	NULL
of	NULL
cells	NULL
include	NULL
PTP1D	NULL
,	NULL
PTP-PEST	NULL
,	NULL
and	NULL
receptor	NULL
protein-tyrosine	NULL
phosphatase	NULL
«	NULL
(	NULL
RPTPa	NULL
)	NULL
(	NULL
7	NULL
,	NULL
10	NULL
,	NULL
23	NULL
)	NULL
.	NULL

The	NULL
first	NULL
two	NULL
PTPases	NULL
are	NULL
inactivated	NULL
by	NULL
PMA	NULL
treatment	NULL
of	NULL
cells	NULL
,	NULL
whereas	NULL
the	NULL
third	NULL
(	NULL
RPTPa	NULL
)	NULL
is	NULL
widely	NULL
expressed	NULL
and	NULL
PMA	NULL
augments	NULL
its	NULL
activity	NULL
in	NULL
several	NULL
cell	NULL
types	NULL
(	NULL
7	NULL
)	NULL
.	NULL

However	NULL
,	NULL
since	NULL
its	NULL
expression	NULL
is	NULL
ubiquitous	NULL
,	NULL
RPTPa	NULL
remains	NULL
a	NULL
possible	NULL
but	NULL
relatively	NULL
unlikely	NULL
candidate	NULL
to	NULL
stimulate	NULL
selective	NULL
dephosphorylation	NULL
of	NULL
Tyk2	NULL
in	NULL
monocytes	NULL
.	NULL

Therefore	NULL
,	NULL
the	NULL
identity	NULL
of	NULL
the	NULL
PTPase	NULL
that	NULL
is	NULL
being	NULL
regulated	NULL
by	NULL
PMA	NULL
in	NULL
these	NULL
cells	NULL
and	NULL
the	NULL
mechanism	NULL
by	NULL
which	NULL
this	NULL
PTPase	NULL
displays	NULL
substrate	NULL
specificity	NULL
for	NULL
Tyk2	NULL
remain	NULL
to	NULL
be	NULL
determined	NULL
.	NULL

ACKNOWLEDGMENTS	NULL
We	NULL
thank	NULL
G.	NULL
R.	NULL
Stark	NULL
and	NULL
I.	NULL
M.	NULL
Kerr	NULL
for	NULL
providing	NULL
the	NULL
cDNA	NULL
clone	NULL
corresponding	NULL
to	NULL
the	NULL
9-27	NULL
RNA	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Ackrill	NULL
,	NULL
A.	NULL
M.	NULL
,	NULL
G.	NULL
R.	NULL
Foster	NULL
,	NULL
C.	NULL
D.	NULL
Laxton	NULL
,	NULL
D.	NULL
M.	NULL
Flavell	NULL
,	NULL
G.	NULL
R.	NULL
Stark	NULL
,	NULL
and	NULL
I.	NULL
M.	NULL
Kerr	NULL
.	NULL

1991	NULL
.	NULL

Inhibition	NULL
of	NULL
the	NULL
cellular	NULL
response	NULL
to	NULL
interferons	NULL
by	NULL
the	NULL
products	NULL
of	NULL
the	NULL
adenovirus	NULL
type	NULL
5	NULL
ElA	NULL
oncogene	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

19	NULL
:	NULL
4387-4393	NULL
.	NULL

2	NULL
.	NULL

Akai	NULL
,	NULL
H.	NULL
,	NULL
and	NULL
A.	NULL
C.	NULL
Larner	NULL
.	NULL

1989	NULL
.	NULL

Phorbol	NULL
ester-mediated	NULL
down-regulation	NULL
of	NULL
an	NULL
interferon-inducible	NULL
gene	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

264:3252-3255	NULL
.	NULL

3	NULL
.	NULL

Col	NULL
ici	NULL
,	NULL
O.	NULL
R.	NULL
,	NULL
P.	NULL
D	NULL
ki	NULL
,	NULL
S.	NULL
M.	NULL
Sweitzer	NULL
,	NULL
A.	NULL
Larner	NULL
,	NULL
and	NULL
R.	NULL
M.	NULL
L.	NULL
Buller	NULL
.	NULL

1995	NULL
.	NULL

Vaccinia	NULL
virus	NULL
B18R	NULL
gene	NULL
encodes	NULL
a	NULL
type	NULL
1	NULL
interferon-binding	NULL
protein	NULL
that	NULL
blocks	NULL
interferon	NULL
«	NULL
transmembrane	NULL
signaling	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270:15974-15978	NULL
.	NULL

4	NULL
.	NULL

David	NULL
,	NULL
M.	NULL
,	NULL
H.	NULL
E.	NULL
Chen	NULL
,	NULL
S.	NULL
Goelz	NULL
,	NULL
A.	NULL
C.	NULL
Larner	NULL
,	NULL
and	NULL
B.	NULL
G.	NULL
Neel	NULL
.	NULL

1995	NULL
.	NULL

Differential	NULL
regulation	NULL
of	NULL
the	NULL
IFNo/B-stimulated	NULL
Jak/Stat	NULL
pathway	NULL
by	NULL
the	NULL
SH2-domain	NULL
containing	NULL
tyrosine	NULL
phosphatase	NULL
SHPTP1	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

15	NULL
:	NULL
7050-7058	NULL
.	NULL

5	NULL
.	NULL

David	NULL
,	NULL
M.	NULL
,	NULL
E.	NULL
F.	NULL
Petricoin	NULL
IH	NULL
,	NULL
C.	NULL
Benjamin	NULL
,	NULL
R.	NULL
Pine	NULL
,	NULL
M.	NULL
J.	NULL
Weber	NULL
,	NULL
and	NULL
A.	NULL
C.	NULL
Larner	NULL
.	NULL

1995	NULL
.	NULL

Requirement	NULL
for	NULL
MAP	NULL
kinase	NULL
(	NULL
ERK2	NULL
)	NULL
activity	NULL
in	NULL
interferon	NULL
o/B-stimulated	NULL
gene	NULL
expression	NULL
through	NULL
Stat	NULL
proteins	NULL
.	NULL

Science	NULL
269:1721-1723	NULL
.	NULL

6	NULL
.	NULL

David	NULL
,	NULL
M.	NULL
,	NULL
G.	NULL
Romero	NULL
,	NULL
Z.	NULL
Zhang	NULL
,	NULL
J.	NULL
E.	NULL
Dixon	NULL
,	NULL
and	NULL
A.	NULL
C.	NULL
Larner	NULL
.	NULL

1993	NULL
.	NULL

In	NULL
vitro	NULL
activation	NULL
of	NULL
the	NULL
transcription	NULL
factor	NULL
ISGF3	NULL
by	NULL
IFNa	NULL
«	NULL
involves	NULL
a	NULL
membrane	NULL
associated	NULL
tyrosine	NULL
phosphatase	NULL
and	NULL
kinase	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268:6593-6599	NULL
.	NULL

7.	NULL
den	NULL
Hertog	NULL
,	NULL
J.	NULL
,	NULL
J.	NULL
Sap	NULL
,	NULL
C.	NULL
Pals	NULL
,	NULL
J.	NULL
Schlessinger	NULL
,	NULL
and	NULL
W.	NULL
Kruijer	NULL
,	NULL
1995	NULL
.	NULL

Stimulation	NULL
of	NULL
receptor-tyrosine	NULL
phosphatase	NULL
«	NULL
activity	NULL
and	NULL
phosphorylation	NULL
by	NULL
phorbol	NULL
ester	NULL
.	NULL

Cell	NULL
Growth	NULL
Differ	NULL
.	NULL

6303-307	NULL
.	NULL

8	NULL
.	NULL

Evans	NULL
,	NULL
R.	NULL
M.	NULL
,	NULL
N.	NULL
Fraser	NULL
,	NULL
E.	NULL
Ziff	NULL
,	NULL
J.	NULL
Weber	NULL
,	NULL
M.	NULL
Wilson	NULL
,	NULL
and	NULL
J.	NULL
E.	NULL
J.	NULL
Darnell	NULL
.	NULL

1977	NULL
.	NULL

The	NULL
initiation	NULL
sites	NULL
for	NULL
RNA	NULL
transcription	NULL
in	NULL
Ad2	NULL
DNA	NULL
.	NULL

Cell	NULL
12:733-739	NULL
.	NULL

9	NULL
.	NULL

Finbloom	NULL
,	NULL
D.	NULL
S.	NULL
,	NULL
D.	NULL
L.	NULL
Hoover	NULL
,	NULL
and	NULL
L.	NULL
M.	NULL
Wahl	NULL
.	NULL

1985	NULL
.	NULL

The	NULL
characteristics	NULL
of	NULL
binding	NULL
of	NULL
human	NULL
recombinant	NULL
interferon	NULL
y	NULL
to	NULL
its	NULL
receptor	NULL
on	NULL
human	NULL
monocytes	NULL
and	NULL
human	NULL
monocyte-like	NULL
cell	NULL
lines	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

135:300-305	NULL
.	NULL

10	NULL
.	NULL

Garton	NULL
,	NULL
A.	NULL
J.	NULL
,	NULL
and	NULL
N.	NULL
K.	NULL
Tonks	NULL
.	NULL

1994	NULL
.	NULL

PTP-PEST	NULL
:	NULL
a	NULL
protein	NULL
tyrosine	NULL
phosphatase	NULL
regulated	NULL
by	NULL
serine	NULL
phosphorylation	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

13:3763-3771	NULL
.	NULL

11	NULL
.	NULL

Gutch	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
N.	NULL
C.	NULL
Reich	NULL
.	NULL

1991	NULL
.	NULL

Response	NULL
of	NULL
the	NULL
interferon	NULL
signal	NULL
transduction	NULL
pathway	NULL
by	NULL
the	NULL
adenovirus	NULL
E1A	NULL
oncogene	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
88:7913-7917	NULL
.	NULL

12	NULL
.	NULL

Igarashi	NULL
,	NULL
K.	NULL
,	NULL
M.	NULL
David	NULL
,	NULL
D.	NULL
S.	NULL
Finbloom	NULL
,	NULL
and	NULL
A.	NULL
C.	NULL
Larner	NULL
.	NULL

1993	NULL
.	NULL

In	NULL
vitro	NULL
activation	NULL
of	NULL
the	NULL
transcription	NULL
factor	NULL
gamma	NULL
interferon	NULL
activation	NULL
factor	NULL
by	NULL
gamma	NULL
interferon	NULL
:	NULL
evidence	NULL
for	NULL
a	NULL
tyrosine	NULL
phosphatase/kinase	NULL
signaling	NULL
cas-cade	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

13:1634-1640	NULL
.	NULL

13	NULL
.	NULL

Igarashi	NULL
,	NULL
K.	NULL
,	NULL
M.	NULL
David	NULL
,	NULL
A.	NULL
C.	NULL
Larner	NULL
,	NULL
and	NULL
D.	NULL
S.	NULL
Finbloom	NULL
.	NULL

1993	NULL
.	NULL

In	NULL
vitro	NULL
activation	NULL
of	NULL
a	NULL
transcription	NULL
factor	NULL
by	NULL
IFNy	NULL
requires	NULL
a	NULL
membrane-associated	NULL
tyrosine	NULL
kinase	NULL
and	NULL
is	NULL
mimicked	NULL
by	NULL
vanadate	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

13:3984-3989	NULL
.	NULL

14	NULL
.	NULL

Igarashi	NULL
,	NULL
K.	NULL
,	NULL
G.	NULL
Garotta	NULL
,	NULL
L.	NULL
Ozmen	NULL
,	NULL
A.	NULL
Ziemiecki	NULL
,	NULL
A.	NULL
F.	NULL
Wilks	NULL
,	NULL
A.	NULL
G.	NULL
Harpur	NULL
,	NULL
A.	NULL
C.	NULL
Larner	NULL
,	NULL
and	NULL
D.	NULL
S.	NULL
Finbloom	NULL
.	NULL

1994	NULL
.	NULL

Interferon-y	NULL
induces	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
interferon-y	NULL
receptor	NULL
and	NULL
regulated	NULL
association	NULL
of	NULL
protein	NULL
tyrosine	NULL
kinases	NULL
,	NULL
Jak1	NULL
and	NULL
Jak2	NULL
,	NULL
with	NULL
its	NULL
receptor	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

269:14333-14336	NULL
.	NULL

15	NULL
.	NULL

Thie	NULL
,	NULL
J.	NULL
N.	NULL
,	NULL
B	NULL
.	NULL

A.	NULL
Witthuhn	NULL
,	NULL
F.	NULL
W.	NULL
Quelle	NULL
,	NULL
K.	NULL
Yamamoto	NULL
,	NULL
W.	NULL
E.	NULL
Thierfelder	NULL
,	NULL
16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

B.	NULL
Kreider	NULL
,	NULL
and	NULL
O.	NULL
Silvennoinen	NULL
.	NULL

1994	NULL
.	NULL

Signaling	NULL
by	NULL
the	NULL
cytokine	NULL
receptor	NULL
superfamily	NULL
:	NULL
JAKS	NULL
and	NULL
STATS	NULL
.	NULL

Trends	NULL
Biochem	NULL
.	NULL

Sci	NULL
.	NULL

19:222-227	NULL
.	NULL

Kalvakolanu	NULL
,	NULL
D.	NULL
V.	NULL
R.	NULL
,	NULL
S.	NULL
K.	NULL
Bandyopadhyay	NULL
,	NULL
M.	NULL
L.	NULL
Harter	NULL
,	NULL
and	NULL
G.	NULL
C.	NULL
Sen.	NULL
1991	NULL
.	NULL

Inhibition	NULL
of	NULL
interferon-inducible	NULL
gene	NULL
expression	NULL
by	NULL
adenovirus	NULL
E1A	NULL
proteins	NULL
:	NULL
block	NULL
in	NULL
transcriptional	NULL
complex	NULL
formation	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
88:7459-7463	NULL
.	NULL

Kanda	NULL
,	NULL
K.	NULL
,	NULL
T.	NULL
Decker	NULL
,	NULL
P.	NULL
Aman	NULL
,	NULL
M.	NULL
Wahlstrom	NULL
,	NULL
A.	NULL
yon	NULL
Gabain	NULL
,	NULL
and	NULL
B.	NULL
Kallin	NULL
.	NULL

1992	NULL
.	NULL

The	NULL
Epstein-Barr	NULL
virus	NULL
nuclear	NULL
antigen	NULL
2-related	NULL
resistance	NULL
towards	NULL
alpha	NULL
interferon	NULL
(	NULL
IFN-	NULL
«	NULL
)	NULL
in	NULL
Burkitt	NULL
's	NULL
lymphoma	NULL
cells	NULL
effects	NULL
induction	NULL
of	NULL
IFN-induced	NULL
genes	NULL
but	NULL
not	NULL
the	NULL
activation	NULL
of	NULL
transcription	NULL
factor	NULL
ISGF-3	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

12:4930-4936	NULL
.	NULL

Klingmuller	NULL
,	NULL
U.	NULL
,	NULL
U.	NULL
Lorenz	NULL
,	NULL
L.	NULL
C.	NULL
Cantley	NULL
,	NULL
B.	NULL
G.	NULL
Neel	NULL
,	NULL
and	NULL
H.	NULL
F.	NULL
Lodish	NULL
.	NULL

1995	NULL
.	NULL

Specific	NULL
recruitment	NULL
of	NULL
SH-PTP1	NULL
to	NULL
the	NULL
erythropoictin	NULL
receptor	NULL
causes	NULL
in-activation	NULL
of	NULL
JAK2	NULL
and	NULL
termination	NULL
of	NULL
proliferative	NULL
signals	NULL
.	NULL

Cell	NULL
80:729-738	NULL
.	NULL

Larner	NULL
,	NULL
A.	NULL
C.	NULL
,	NULL
M.	NULL
David	NULL
,	NULL
G.	NULL
M.	NULL
Feldman	NULL
,	NULL
K.	NULL
Igarashi	NULL
,	NULL
R.	NULL
H.	NULL
Hackett	NULL
,	NULL
D.	NULL
A.	NULL
S.	NULL
Webb	NULL
,	NULL
S.	NULL
M.	NULL
Sweitzer	NULL
,	NULL
E.	NULL
F.	NULL
Petricoin	NULL
III	NULL
,	NULL
and	NULL
D.	NULL
S.	NULL
Finbloom	NULL
.	NULL

1993	NULL
.	NULL

Tyrosine	NULL
phosphorylation	NULL
of	NULL
DNA	NULL
binding	NULL
proteins	NULL
by	NULL
multiple	NULL
cytokines	NULL
.	NULL

Science	NULL
261:1730-1733	NULL
.	NULL

Larner	NULL
,	NULL
A.	NULL
C.	NULL
,	NULL
and	NULL
D.	NULL
S.	NULL
Finbloom	NULL
.	NULL

1995	NULL
.	NULL

Protein	NULL
tyrosine	NULL
phosphorylation	NULL
as	NULL
a	NULL
mechanism	NULL
which	NULL
regulates	NULL
cytokine	NULL
activation	NULL
of	NULL
early	NULL
response	NULL
genes	NULL
.	NULL

Biochim	NULL
.	NULL

Biophys	NULL
.	NULL

Acta	NULL
1266:278-287	NULL
.	NULL

Levy	NULL
,	NULL
D.	NULL
E.	NULL
,	NULL
D.	NULL
S.	NULL
Kessler	NULL
,	NULL
R.	NULL
Pine	NULL
,	NULL
N.	NULL
Reich	NULL
,	NULL
and	NULL
J.	NULL
E.	NULL
Darnell	NULL
.	NULL

1988	NULL
.	NULL

Interferon-induced	NULL
nuclear	NULL
factors	NULL
that	NULL
bind	NULL
a	NULL
shared	NULL
promoter	NULL
element	NULL
correlate	NULL
with	NULL
positive	NULL
and	NULL
negative	NULL
transcriptional	NULL
control	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

2:383-393	NULL
.	NULL

Muller	NULL
,	NULL
M.	NULL
,	NULL
et	NULL
al	NULL
.	NULL

1993	NULL
.	NULL

The	NULL
protein	NULL
tyrosine	NULL
kinase	NULL
JAK1	NULL
complements	NULL
defects	NULL
in	NULL
the	NULL
interferon-o/8	NULL
and	NULL
-y	NULL
signal	NULL
transduction	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
366:129-135	NULL
.	NULL

Peraldi	NULL
,	NULL
P.	NULL
,	NULL
Z.	NULL
Zhao	NULL
,	NULL
C.	NULL
Filloux	NULL
,	NULL
E.	NULL
H.	NULL
Fischer	NULL
,	NULL
and	NULL
E.	NULL
Van	NULL
Obberghen	NULL
.	NULL

1994	NULL
.	NULL

Protein-tyrosine-phosphatase	NULL
2C	NULL
is	NULL
phosphorylated	NULL
and	NULL
inhibited	NULL
by	NULL
44-kDa	NULL
mitogen-activated	NULL
protein	NULL
kinase	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
91:5002-5006	NULL
.	NULL

Petricoin	NULL
,	NULL
E.	NULL
F.	NULL
,	NULL
R.	NULL
H.	NULL
Hackett	NULL
,	NULL
H.	NULL
Akai	NULL
,	NULL
K.	NULL
Igarashi	NULL
,	NULL
D.	NULL
S.	NULL
Finbloom	NULL
,	NULL
and	NULL
A.	NULL
C.	NULL
Larner	NULL
.	NULL

1992	NULL
.	NULL

Modulation	NULL
of	NULL
interferon	NULL
signaling	NULL
in	NULL
human	NULL
fibroblasts	NULL
by	NULL
phorbol	NULL
esters	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

12:4486-4495.	NULL
.	NULL

Petricoin	NULL
,	NULL
E.	NULL
F.	NULL
,	NULL
II	NULL
,	NULL
M.	NULL
David	NULL
,	NULL
H.	NULL
Fang	NULL
,	NULL
P.	NULL
Grimley	NULL
,	NULL
A.	NULL
C.	NULL
Larner	NULL
,	NULL
and	NULL
S.	NULL
Vande	NULL
Pol	NULL
.	NULL

1994	NULL
.	NULL

Human	NULL
cancer	NULL
cell	NULL
lines	NULL
express	NULL
a	NULL
negative	NULL
transcriptional	NULL
regulator	NULL
of	NULL
the	NULL
interferon	NULL
regulatory	NULL
factor	NULL
family	NULL
of	NULL
DNA-binding	NULL
proteins	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14:1477-1486	NULL
.	NULL

Platanias	NULL
,	NULL
L.	NULL
C.	NULL
,	NULL
and	NULL
O.	NULL
R.	NULL
Colamonici	NULL
.	NULL

1992	NULL
.	NULL

Interferon	NULL
«	NULL
induces	NULL
rapid	NULL
tyrosine	NULL
phosphorylation	NULL
on	NULL
the	NULL
a	NULL
subunit	NULL
of	NULL
its	NULL
receptor	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

267:24053-24057	NULL
.	NULL

Reich	NULL
,	NULL
N.	NULL
,	NULL
B.	NULL
Evans	NULL
,	NULL
D.	NULL
E.	NULL
Levy	NULL
,	NULL
D.	NULL
Fahey	NULL
,	NULL
E.	NULL
Knight	NULL
,	NULL
and	NULL
J.	NULL
E.	NULL
Darnell	NULL
,	NULL
Jr.	NULL
1987	NULL
.	NULL

Interferon-induced	NULL
transcription	NULL
of	NULL
a	NULL
gene	NULL
encoding	NULL
a	NULL
15-kDa	NULL
protein	NULL
depends	NULL
on	NULL
an	NULL
upstream	NULL
enhancer	NULL
element	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
84:6394-6398	NULL
.	NULL

Reid	NULL
,	NULL
L.	NULL
E.	NULL
,	NULL
A.	NULL
H.	NULL
Brasnett	NULL
,	NULL
C.	NULL
S.	NULL
Gilbert	NULL
,	NULL
A.	NULL
C.	NULL
G.	NULL
Porter	NULL
,	NULL
D.	NULL
R.	NULL
Gewert	NULL
,	NULL
G.	NULL
R.	NULL
Stark	NULL
,	NULL
and	NULL
I.	NULL
M.	NULL
Kerr	NULL
.	NULL

1989	NULL
.	NULL

A	NULL
single	NULL
DNA	NULL
response	NULL
element	NULL
can	NULL
confer	NULL
inducibility	NULL
by	NULL
both	NULL
alpha-	NULL
and	NULL
gamma-interferons	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
86:840-844	NULL
.	NULL

Symons	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
A.	NULL
Alcami	NULL
,	NULL
and	NULL
G.	NULL
L.	NULL
Smith	NULL
.	NULL

1995	NULL
.	NULL

Vaccinia	NULL
virus	NULL
encodes	NULL
a	NULL
soluble	NULL
type	NULL
1	NULL
interferon	NULL
receptor	NULL
of	NULL
novel	NULL
structure	NULL
and	NULL
broad	NULL
species	NULL
specificity	NULL
.	NULL

Cell	NULL
81:551-560	NULL
.	NULL

Tang	NULL
,	NULL
T.	NULL
L.	NULL
,	NULL
R.	NULL
M.	NULL
Freeman	NULL
,	NULL
Jr.	NULL
,	NULL
A.	NULL
M.	NULL
O'Reilly	NULL
,	NULL
B.	NULL
G.	NULL
Neel	NULL
,	NULL
and	NULL
S.	NULL
Y.	NULL
Sokol	NULL
.	NULL

1995	NULL
.	NULL

The	NULL
SH2-containing	NULL
protein-tyrosine	NULL
phosphatase	NULL
SH-PTP2	NULL
is	NULL
required	NULL
upstream	NULL
of	NULL
MAP	NULL
kinase	NULL
for	NULL
early	NULL
Xenopus	NULL
development	NULL
.	NULL

Cell	NULL
80	NULL
:	NULL
473-483	NULL
.	NULL

Uze	NULL
,	NULL
G.	NULL
,	NULL
G.	NULL
Lutfalla	NULL
,	NULL
and	NULL
I.	NULL
Gresser	NULL
.	NULL

1990	NULL
.	NULL

Genetic	NULL
transfer	NULL
of	NULL
a	NULL
functional	NULL
interferon	NULL
a	NULL
receptor	NULL
into	NULL
mouse	NULL
cells	NULL
:	NULL
cloning	NULL
and	NULL
expression	NULL
of	NULL
its	NULL
cDNA	NULL
.	NULL

Cell	NULL
60:225-234	NULL
.	NULL

Veals	NULL
,	NULL
S.	NULL
A.	NULL
,	NULL
C.	NULL
Schindler	NULL
,	NULL
D.	NULL
Leonard	NULL
,	NULL
X.	NULL
Fu	NULL
,	NULL
R.	NULL
Aebersold	NULL
,	NULL
J.	NULL
E.	NULL
Darnell	NULL
,	NULL
and	NULL
D.	NULL
E.	NULL
Levy	NULL
.	NULL

1992	NULL
.	NULL

Subunit	NULL
of	NULL
an	NULL
alpha-interferon-responsive	NULL
transcription	NULL
factor	NULL
is	NULL
related	NULL
to	NULL
interferon	NULL
regulatory	NULL
factor	NULL
and	NULL
myb	NULL
families	NULL
of	NULL
DNA-binding	NULL
proteins	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

12:3315-3324	NULL
.	NULL

Velazquez	NULL
,	NULL
L.	NULL
,	NULL
M.	NULL
Fellous	NULL
,	NULL
G.	NULL
R.	NULL
Stark	NULL
,	NULL
and	NULL
S.	NULL
Pellegrini	NULL
.	NULL

1992	NULL
.	NULL

A	NULL
protein	NULL
tyrosine	NULL
kinase	NULL
in	NULL
the	NULL
interferon	NULL
«	NULL
/f	NULL
signaling	NULL
pathway	NULL
.	NULL

Cell	NULL
70:313-322	NULL
.	NULL

Velazquez	NULL
,	NULL
L.	NULL
,	NULL
K.	NULL
E.	NULL
Mogensen	NULL
,	NULL
G.	NULL
Barbieri	NULL
,	NULL
M.	NULL
Fellous	NULL
,	NULL
G.	NULL
Uze	NULL
,	NULL
and	NULL
S.	NULL
Pellegrini	NULL
.	NULL

1995	NULL
.	NULL

Distinct	NULL
domains	NULL
of	NULL
the	NULL
protein	NULL
tyrosine	NULL
kinase	NULL
tyk2	NULL
required	NULL
for	NULL
binding	NULL
of	NULL
interferon-	NULL
«	NULL
/8	NULL
and	NULL
for	NULL
signal	NULL
transduction	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270:3327-3334	NULL
.	NULL

Wilson	NULL
,	NULL
K.	NULL
C.	NULL
,	NULL
and	NULL
D.	NULL
S.	NULL
Finbleom	NULL
.	NULL

1992	NULL
.	NULL

Interferon	NULL
:	NULL
y	NULL
rapidly	NULL
induces	NULL
in	NULL
human	NULL
monocytes	NULL
a	NULL
DNA-binding	NULL
factor	NULL
that	NULL
recognizes	NULL
the	NULL
y	NULL
response	NULL
region	NULL
within	NULL
the	NULL
promoter	NULL
of	NULL
the	NULL
gene	NULL
for	NULL
the	NULL
high-affinity	NULL
Foy	NULL
receptor	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
89:11964-11968	NULL
.	NULL

Zhao	NULL
,	NULL
Z.	NULL
,	NULL
S-H.	NULL
Shen	NULL
,	NULL
and	NULL
E.	NULL
D.	NULL
Fischer	NULL
.	NULL

1994	NULL
.	NULL

Phorbol	NULL
ester-induced	NULL
expression	NULL
,	NULL
phosphorylation	NULL
,	NULL
and	NULL
translocation	NULL
of	NULL
protein-tyrosine-phosphatase	NULL
1C	NULL
in	NULL
HL-60	NULL
cells	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
91:5007-5011	NULL
.	NULL

